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DISTRIBUTION-FREE MULTISAMPLE TEST BASED ON OPTIMAL
MATCHING WITH APPLICATIONS TO SINGLE CELL GENOMICS
DIVYANSH AGARWAL†, SOMABHA MUKHERJEE†, BHASWAR B. BHATTACHARYA,
AND NANCY R. ZHANG
Abstract. In this paper we propose a nonparametric graphical test based on optimal
matching, for assessing the equality of multiple unknown multivariate probability distri-
butions. Our procedure pools the data from the different classes to create a graph based
on the minimum non-bipartite matching, and then utilizes the number of edges connecting
data points from different classes to examine the closeness between the distributions. The
proposed test is exactly distribution-free (the null distribution does not depend on the dis-
tribution of the data) and can be efficiently applied to multivariate as well as non-Euclidean
data, whenever the inter-point distances are well-defined. We show that the test is univer-
sally consistent, and prove a distributional limit theorem for the test statistic under general
alternatives. Through simulation studies, we demonstrate its superior performance against
other common and well-known multisample tests. In scenarios where our test suggests dis-
tributional differences across classes, we also propose an approach for identifying which class
or group contributes to this overall difference. The method is applied to single cell transcrip-
tomics data obtained from the peripheral blood, cancer tissue, and tumor-adjacent normal
tissue of human subjects with hepatocellular carcinoma and non-small-cell lung cancer. Our
method unveils patterns in how biochemical metabolic pathways are altered across immune
cells in a cancer setting, depending on the tissue location. All of the methods described
herein are implemented in the R package multicross.
1. Introduction
Given K multivariate probability distributions F1, F2, . . . , FK , the K-sample problem is to
test the hypotheses
H0 : F1 = · · · = FK versus H1 : Fs 6= Ft, for some 1 ≤ s < t ≤ K. (1.1)
This is a classical problem in statistical inference which has been extensively studied in the
parametric regime, where the distributions are assumed to have certain, low-dimensional
functional forms. Parametric methods, however, often perform poorly for misspecified mod-
els and for high-dimensional problems, especially when the number of nuisance parameters
is large. This necessitates the development of non-parametric methods, which make no dis-
tributional assumptions on the data, but are still powerful for a wide class of alternatives.
Moreover, with the recent accumulation of high-dimensional and non-Euclidean data aris-
ing from genomics, social networks, bioinformatics, and finance, it is imperative to develop
non-parametric methods which are computationally efficient, robust and applicable to the
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various kinds of modern data types. In this paper, we consider non-parametric tests for
the K-sample problem, which are exactly distribution-free, that is, tests for which the null
distribution does not depend on the underlying (unknown) distribution of the data. This
property is particularly desirable, because such tests can be directly calibrated under the null
irrespective of the distribution or type of the data, making them readily applicable in a wide
range of problems.
Nonparametric testing of two multivariate distributions has a long history, which has
spawned renewed interest in light of modern applications. For univariate data, there are sev-
eral celebrated distribution-free two-sample tests such as the Kolmogorov-Smirnov maximum
deviation test [42], the Wald-Wolfowitz runs test [44], and the Mann-Whitney rank-sum test
[29] (see the textbook [15] for more on these tests). Efforts to generalize these methods to
higher dimensions go back to Weiss [45] and Bickel [7]. Friedman and Rafsky [13] proposed
the first computationally efficient 2-sample test, which applies to high-dimensional data. The
Friedman-Rafsky test, which can be viewed as a generalization of the univariate runs test,
computes the Euclidean minimal spanning tree (MST)1 of the pooled sample, and rejects the
null if the number of edges with endpoints in different samples is small. Variants of this test
based on nearest-neighbor graphs were considered by Henze [20] and Schilling [41]. Recently,
Chen and Friedman [9] suggested novel modifications of this method for high-dimensional
and object data, and Chen et al. [10] proposed new and powerful tests to deal with the issue
of unequal sample sizes. Asymptotic properties of these tests can be studied in a general as-
ymptotic framework introduced in [6]. Another computationally efficient 2-sample test based
on the concept of multivariate ranks, defined using optimal transport, was recently proposed
by Ghosal and Sen [14].
Even though many of these methods can be effectively used in high-dimensional problems,
none of them inherit the exact distribution-free property of the univariate tests. A break-
through in this direction was made relatively recently by Rosenbaum [39], who proposed the
crossmatch test, a multivariate two-sample test based on the minimum non-bipartite matching
(Definition 2.1) of the pooled sample. This test is exactly distribution-free in finite samples
and computationally efficient (the test statistic can be computed in time which is polynomial
in both the number of samples and the dimension of the data), making it particular attractive
for high-dimensional applications. This test has also found many interesting applications in
causal inference, especially in assessing balance between covariates in a treatment group and
a matched control group [11, 18, 19, 31]. More recently, Biswas et al. [8] proposed another
two-sample test based on Hamiltonian cycles, which is also distribution-free in finite sam-
ples. However, unlike the minimum non-bipartite matching, computing the minimum weight
Hamiltonian path is NP-hard, making this test computationally prohibitive beyond small
sample sizes.
Here, we study nonparametric distribution-free tests for the general K-sample problem
(1.1). As expected, this problem is well-understood in dimension 1. Mood [32] considered
the K-sample generalization of the runs test, and Kruskal and Wallis [24, 25] derived the
1Given a finite set S ⊂ Rd, the minimum spanning tree (MST) of S is a connected graph with vertex-set S
and no cycles, which has the minimum weight, where the weight of a graph is the sum of the distances of its
edges.
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K-sample analogue of the Mann-Whitney test, both of which are distribution-free. Our
interest is in devising efficient distribution-free methods, which are powerful for a wide range
of alternatives in arbitrary dimensions. We are motivated by applications in high-throughput
biological experiments, where the multisample problem often arises. For instance, it is not
uncommon to examine the distribution of a set of high-dimensional features across various
models or conditions. Recently, single cell technologies have made it possible to profile the
expression of tens of thousands of genes across thousands of cells. The cells might belong
to different subtypes, where the K types are characterized based on some functional or
morphological parameter. In this setting, determining whether the expression of a set of
genes, corresponding to a particular biochemical pathway or function, belong to the same or
different distribution across the K groups can yield insights into cellular processes and the
underlying biological system.
Even though the high-dimensional multisample problem manifests itself in various modern
applications, methodological progress to address this problem has been limited. A nearest-
neighbor based test for testing the equality of multiple distributions with categorical compo-
nents was considered in [33]. Recently, Petrie [36] considered the direct generalization of the
Friedman-Rafsky and crossmatch tests, which counts the number of edges across the different
samples in the geometric graph (MST or matching) constructed on the pooled sample. How-
ever, this test tends to lose power with increases in dimension and/or the number of classes,
and the mathematical properties of this test have not been investigated.
We propose a new graph-based multisample test based on optimal matchings. To compute
the test statistic, we construct the minimum non-bipartite matching of the pooled sample,
compute the K ×K matrix of cross-counts (the (s, t)-th element of this matrix is the num-
ber of edges in the matching from sample s to sample t), then combine these counts using
their Mahalanobis distance. We show that this test is exactly distribution-free under the null
(Proposition 2.1), derive its asymptotic null distribution (Theorem 2.3), and demonstrate
its consistency under general alternatives (Theorem 2.4). We also prove a conditional cen-
tral limit theorem (CLT) of the entire vector of cross-counts under the alternative (Section
4). More precisely, we show that the cross-counts, centered by their means, conditional on
the pooled sample and scaled appropriately, converge in distribution to a multivariate nor-
mal distribution under general alternatives. As a consequence, we obtain a distributional
limit theorem for the proposed test statistic under the alternative, which to the best of our
knowledge, is a new result even for the 2-sample case (where the proposed test statistic is
equivalent to Rosenbaum’s 2-sample crossmatch test). Therefore, this result adds to our the-
oretical understanding of the crossmatch and general matching-based tests, which includes
the proposed method and the baseline generalizations considered in [36]. In Section 3 we
compare the power of our test with other existing tests for various alternatives. Our exper-
iments demonstrate that the proposed method outperforms other relevant parametric and
non-parametric tests in a diverse set of simulation settings.
Lastly, we demonstrate the broad potential of our method on real data examples from the
single cell biology domain, where we use our test to investigate whether the activities of bio-
logical pathways across K closely-related cell types are conserved. Single cell data is sparse
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count data with many zeros, so it is difficult to transform it to conform to normal distribu-
tion assumptions. Moreover, gene expression has complex correlation structure and thus any
parametric model would require many nuisance parameters. Therefore, our novel crossmatch-
based method, being nonparametric and distribution free, is especially fitting. We show the
utility of our proposed test in the comparison of the distribution of gene sets (as a proxy for
examining biochemical pathways) across cell populations using single cell RNA-sequencing
(scRNA-seq) data (Section 5). Our method successfully recapitulates known biology by de-
tecting differential distribution of metabolic pathways which are known to be disparate across
T cell subtypes. We also discovered pathways such as purine metabolism that differed across
T cell subtypes, irrespective of whether the sequenced cells were obtained from blood, liver
cancer tissue, lung cancer tissue, or tumor-adjacent normal tissue. Moreover, we ascertain
that our method can be used to narrow down gene sets that are differentially distributed
across cell types, thereby facilitating its use in single cell clustering and visualization algo-
rithms. Altogether, as illustrated through real case studies, our proposed method combines
statistical innovation to answer practical, scientifically relevant questions.
2. Multisample distribution-free tests based on optimal matching
Recall the K-sample hypothesis (1.1), and assume that for every s ∈ [K] := {1, 2, . . . ,K},
we are given Ns i.i.d. observations X
(s) := {X(s)1 , X(s)2 , . . . , X(s)Ns } from the distribution Fs.
In this section we describe a novel distribution-free, computationally efficient K-sample test,
based on the minimum non-bipartite matching, which can be readily used for data in arbitrary
metric spaces, such as high dimensional data, functional data, and object data.
We begin with the formal definition of a minimum non-bipartite matching. For simplicity,
we will assume throughout that the total number of samples N =
∑K
s=1Ns := 2I is even;
otherwise, we can add or delete a sample point to make it even.
Definition 2.1. Given a finite S ⊂ Rd and a symmetric distance matrixD := ((d(a, b)))a6=b∈S ,
a non-bipartite matching of S is a partition of the elements of S into I = N2 non-overlapping
sets of size 2 each, that is,
S = S1
⋃
S2
⋃
· · ·
⋃
SI , where |Sa| = 2 and Sa ∩ Sb = ∅, for 1 ≤ a 6= b ≤ I.
The weight of a non-bipartite matching is the sum of the distances between the I matched
pairs. A minimum non-bipartite matching of S is a matching which has the minimum weight
over all matchings of S. (In case of multiple minimizers any one of them can be chosen.)
The minimum non-bipartite matching graph G (S) = (V (G (S)), E(G (S))) is the graph with
vertex set V (G (S)) = S and edge set E(G (S)) = {S1, S2, . . . , SI}, consisting of the I disjoint
pairs.
The 2-sample cross-match (CM) test proposed by Rosenbaum [39] rejects the null hypoth-
esis in (1.1) for small values of
R2,N :=
N1∑
i=1
N2∑
j=1
1{(X(1)i , X(2)j ) ∈ E(G (X ))}, (2.1)
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where X := {X(1),X(2)} is the pooled sample. Note that the statistic R2,N counts the
number of matched edges in the pooled sample with one end point in sample 1 and the other
endpoint in sample 2 (the “cross-matches”), which is expected to be small when the two
distributions are different.
Figure 1. Illustration of a minimum non-bipartite matching for 100 points in 3-
dimensions with 4 classes, and the different cross/pure counts.
Here, we consider two generalizations of the CM statistic when there are more than 2
samples, based on the minimum non-bipartite matching of the pooled sample. In this case,
denoting the pooled sample by X := {X(1),X(2), . . . ,X(K)}, we define, for 1 ≤ s 6= t ≤ K,
the (s, t)-cross count as the number of matched edges in the pooled sample with one endpoint
in sample s and the other end-point in sample t, which is denoted by
ast(G (X )) :=
Ns∑
i=1
Nt∑
j=1
1{(X(s)i , X(t)j ) ∈ E(G (X ))}. (2.2)
For each s ∈ [K], we also define the (s, s)-pure count as the number of matched edges in the
pooled sample with both endpoints in sample s, which is denoted by
ass(G (X )) :=
1
2
Ns∑
i=1
Ns∑
j=1
1{(X(s)i , X(s)j ) ∈ E(G (X ))}. (2.3)
The matrix of cross/pure counts AN (G (X )) = (ast(G (X )))1≤s,t≤K will be referred to as the
count matrix. (Hereafter, we will drop the dependence on G (X ) from AN (G (X )) and its
elements ast(G (X ), whenever it is clear from the context.) Figure 1 shows the cross/pure
counts for a sample of 100 points in 3-dimensions with 4 classes.
We show below in Proposition 2.1, that the joint distribution of the elements of the count
matrix is exactly distribution-free under the null. Therefore, we can construct distribution-
free tests for (1.1) by considering real-valued functions of the cross-matrix, as follows:
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• The multisample crossmatch (MCM) test rejects the null in (1.1) for small values of
the statistic
RK,N :=
∑
1≤s<t≤K
ast(G (X )). (2.4)
This direct generalization of the 2-sample cross-match statistic (recall (2.1)), which
counts the total number of cross edges in the matching constructed using the pooled
sample, was considered in [36]. Here, we derive its asymptotic properties, and use it
as a baseline for empirical comparisons.
• There are many natural multivariate alternatives where the MCM test described
above performs poorly, especially when the dimension is large and the number of
groups is big. To circumvent this issue, we propose a new test statistic based on the
Mahalanobis distance of the observed cross-counts, which rejects the null for large
values of
SK,N := (AN − EH0AN )>Cov−1H0(AN ) (AN − EH0AN ) , (2.5)
where AN is the vector of length
(
K
2
)
corresponding to the cross-counts (the upper-
triangular part of AN ),
2 and EH0(AN ) and CovH0(AN ) denote the mean and the
covariance matrix of AN under the null hypothesis, respectively (exact formulas are
given below in Proposition 2.2 and the invertibility of CovH0(AN ) is proved in Lemma
C.1). We refer to this test as the multisample Mahalanobis crossmatch (MMCM) test.3
Note that adjusting by the sample covariance matrix brings the cross-counts in the
same scale, which makes SK,N a more appropriate measure of the centrality of the
empirical cross-counts, leading to significant power improvements when K becomes
large.
2.1. Exact Null Distribution. The following proposition shows that the joint distribution
of the elements of the count matrix is distribution-free under the null, that is, it does not
depend on the unknown distribution F1 = · · · = FK .
Proposition 2.1. Let AN = ((ast))1≤s,t≤K be as defined in (2.2) and (2.3). Then
PH0
(
AN = b
∣∣∣X ) = 1( N
N1,...,NK
) · 2∑1≤s<t≤K bstI!∏
1≤s≤t≤K bst!
, for b = ((bst))1≤s,t≤K ∈ B, (2.6)
where B is the set of all symmetric K × K matrices b = ((bst)) with non-negative integer
entries, satisfying 2bss +
∑
t6=s bst = Ns, for all s ∈ [K]. As a consequence, the statistics
RK,N and SK,N defined above, are distribution-free under H0.
2More formally, AN := (a12, . . . , a1K , a23, . . . , a2K , . . . , aK−2,K−1, aK−2,K , aK−1,K)
>, the vector obtained by
concatenating the rows of AN in the upper triangular part.
3When K = 2 (the two-sample problem), the tests based on R2,N and S2,N are equivalent: In this case,
the vector AN has only 1 element which is the number of cross-matches a11, and (2.5) simplifies to S2,N =
(R2,N−EH0 (R2,N ))
2
VarH0 (R2,N )
, which is the square of the standardized CT statistic (2.1).
MULTISAMPLE TESTS BASED ON OPTIMAL MATCHINGS 7
Proof. Note that
2ass +
∑
t6=s
ast = Ns, for each s ∈ [K],
since all edges in the graph G (X ) are disjoint, and each (s, s)-edge has both endpoints in
sample s and each (s, t)-edge, where s 6= t, has one of its endpoints in sample s. Therefore,
the distribution of the cross-count matrix AN is supported on the set B defined above.
Now, given b ∈ B and the pooled sample X , there are
2
∑
1≤s<t≤K bstI!∏
1≤s≤t≤K bst!
ways of forming the classes X(1), . . . ,X(K), such that ast = bst for all s, t ∈ [K]. This comes
from first assigning the I matched pairs such that there are bst pairs corresponding to the
(s, t)-counts, for 1 ≤ s ≤ t ≤ K, in I!∏
1≤s≤t≤K bst!
ways, and then, for each of the bst cross-
matched pairs, assigning either one of the end points s or t in 2bst ways, for 1 ≤ s < t ≤ K.
Since, the random vector (X
(1)
1 , . . . , X
(1)
N1
, . . . , X
(K)
1 , . . . , X
(K)
NK
) is exchangeable underH0, each
of these classifications has probability
(
N
N1,...,NK
)−1
. Hence, (2.6) follows.
Note that the RHS of (2.6) does not depend on X , which implies PH0(AN = b|X ) =
PH0(AN = b). Therefore, the statistics RK,N and SK,N , which are functions of the matrix
AN , are distribution-free under H0. 
The mean and covariances of this distribution, which are required for computing the
MMCM statistic, can be easily derived:
Proposition 2.2. Let AN be as in (2.5). The entries of the mean vector of EH0AN are
given by:
EH0(ast) =
{
NsNt
N−1 if s < t,
Ns(Ns−1)
2(N−1) if s = t.
(2.7)
The entries of the covariance matrix CovH0(AN ) are as follows:
• If 1 ≤ s1 6= s2 ≤ K, VarH0(as1s2) = Ns1Ns2 (Ns1−1)(Ns2−1)(N−1)(N−3) +
Ns1Ns2
N−1
(
1− Ns1Ns2N−1
)
.
• If 1 ≤ s1 6= s2 6= s3 ≤ K, CovH0(as1s2 , as1s3) = Ns1 (Ns1−1)Ns2Ns3(N−1)(N−3) −
N2s1Ns2Ns3
(N−1)2 .
• If 1 ≤ s1 6= s2 6= s3 6= s4 ≤ K, CovH0(as1s2 , as3s4) = 2Ns1Ns2Ns3Ns4(N−1)2(N−3) .
The proof of the proposition is given in Appendix A.1. It follows by a direct combinatorial
analysis and observing that, under the permutation null distribution, all possible
(
N
N1,N2,...,NK
)
relabelings of the data are equally likely.
2.2. Asymptotic Null Distribution. In theory, the exact cutoff for the MMCM test can
be obtained using the quantiles of the distribution in (2.6). Another alternative is to use the
exchangeability of the data under H0, and perform a permutation test. However, both these
approaches are computationally cumbersome when the sample size increases. In this case, it
is more convenient to use rejection regions based on the asymptotic null distribution. This
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is derived in the theorem in the usual limiting regime where N →∞ such that(
N1
N
,
N2
N
, . . . ,
NK
N
)
→ (p1, p2, . . . , pK) ∈ (0, 1)K , (2.8)
where
∑K
s=1 ps = 1.
Theorem 2.3. Under the null H0,
Cov
− 1
2
H0
(AN ) (AN − EH0AN ) D−→ N(K2 )(0, I). (2.9)
This implies, under H0, the MMCM statistic SK,N
D−→ χ2
(K2 )
, as N → ∞, and the test with
rejection region {
SK,N > χ
2
(K2 ),1−α
}
, (2.10)
is asymptotically level α.4
The proof of the theorem is given in Appendix A.2. Note that, by Proposition 2.2, the
elements of CovH0(AN )/N has a non-degenerate limit, that is, there is a
(
K
2
) × (K2 ) matrix
Γ, such that CovH0(AN )/N → Γ. An application of the Slutsky’s theorem and (2.9) then
implies,
AN − EH0AN√
N
D→ N(K2 )(0,Γ),
and the test with rejection region{
(AN − EH0AN )> Γ−1 (AN − EH0AN )
N
> χ2
(K2 ),1−α
}
, (2.11)
is also asymptotically level α.
Note that Theorem 2.3 gives the asymptotic normality of entire cross-count vector, which
implies the normality of any linear function of the cross-count vector, in particular, the MCM
statistic (2.4) as well. More formally, (2.9) implies, under H0,
QK,N :=
RK,N − EH0(RK,N )√
VarH0(RK,N )
D→ N(0, 1), (2.12)
where, by Proposition 2.2, EH0(RK,N ) =
∑
s<tNsNt
N−1 and
VarH0(RK,N ) =
G1
N − 1
(
1− G1
N − 1
)
+
G21 −G1 − 2G2
(N − 1)(N − 3) ,
with G1 :=
∑
1≤s<t≤K NsNt and G2 :=
1
2
∑K
s=1Ns(N − Ns)(N − Ns − 1). Therefore, the
asymptotically level α test has rejection region {QK,N < zα}, where zα is the α-th quantile
of the standard normal distribution.
Remark 2.1. (Non-Euclidean data) As the conditional (permutation) null distribution is
same as the unconditional distribution (by Proposition 2.1), it follows from the proof of
4For p ≥ 1, Np(µ,Σ) denotes the multivariate normal distribution with mean µ ∈ Rp and covariance matrix
Σ ∈ Rp×p. Moreover, χ2n denotes the chi-squared distribution with n degrees of freedom and χ2n,1−α denotes
the (1− α)-th quantile of the χ2n distribution.
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Theorem 2.3 that the asymptotic null distributions for SK,N and QK,N obtained above hold
verbatim for non-Euclidean spaces, as long as a similarity measure on the sample space can
be defined. This is one of the highlights of tests based on inter-point distances, which makes
them readily applicable for combinatorial and object data [9, 10]. Maa et al. [28] provided
theoretical motivations for using tests based on inter-point distances, by showing that, under
mild conditions, two multivariate distributions are equivalent if and only if the distributions
of inter-point distances within each distribution and between the distributions are equivalent.
2.3. Consistency. In this section, we show the consistency of the tests discussed above.
To this end, assume that the K distributions F1, F2, . . . , FK have densities f1, f2, . . . , fK ,
respectively, with respect to the Lebesgue measure on Rd. A test is said to be universally
consistent for the hypothesis (1.1) if the power of the test converges to 1, whenever there
exists 1 ≤ s 6= t ≤ K such that fs 6= ft on a set of positive Lebesgue measure. Recently,
Arias-Castro and Pelletier [3] showed that the 2-sample CM test is universally consistent.
Their arguments can be easily adapted to show the universal consistency of the MCM and
MMCM tests:
Theorem 2.4. In the usual limiting regime (2.8), 1NAN → H = ((hst))1≤s,t≤N almost
surely, where
hst =

pspt
´
Rd
fs(z)ft(z)∑K
a=1 pafa(z)
dz if s 6= t,
p2s
2
´
Rd
f2s (z)∑K
a=1 pafa(z)
dz otherwise.
(2.13)
This implies that the MCM test with rejection {QK,N < zα} and the MMCM test with rejec-
tion region (2.11) are universally consistent.
The proof of the theorem is given in Appendix A.3. The limit in (2.13) implies that the
MCM statistic (recall (2.4))
RK,N
a.s.→
∑
1≤s<t≤K
hst := H(f1, f2, . . . , fK) :=
1
2 − tr(H). (2.14)
The consistency of the MCM and the MMCM tests then follows from the fact that
H(f1, f2, . . . , fK) ≤ H(f, f, . . . , f),
and equality holds if and only if f1 = f2 = · · · = fK outside a set of Lebesgue measure 0
(details given Appendix A.3).
Remark 2.2. (Henze-Penrose divergence) In the case K = 2, the limiting constant h12 equals
1− δ(f1, f2), where
δ(f1, f2) =
ˆ
p21f
2
1 (x) + p
2
2f
2
2 (x)
p1f1(x) + p2f2(x)
dx,
is the well-known Henze-Penrose divergence between probability measures [16]. This quantity
appears as the almost sure limit of a large class of graph-based 2-sample tests, which includes
the Friedman-Rafsky test [21], the nearest-neighbor based tests [20], and the CM test [3],
and has an interesting interpretation in terms of treatment-control assignment, using the
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propensity score [19]. For general K, the limit hst in (2.13) is a multi-sample generalization
of the Henze-Penrose integral, which aggregated over 1 ≤ s < t ≤ K (as in the RHS of
(2.14)), is a global measure of dissimilarity between the densities f1, f2, . . . , fK .
3. Power Comparisons
In this section, we illustrate the effectiveness of the tests described above by comparing
their power with various other parametric and non-parametric tests, for several alternative
hypotheses across different dimensions and number of groups. In Section 3.1 we illustrtate
the advantage of using optimal matchings by comparing the performance of the MCM and
MCMM tests with the multisample Friedman-Rafsky test (a natural generalization of the 2-
sample Friedman-Rafsky test [13], where the optimal matching is replaced with the minimum
spanning tree (MST)). In Section 3.2 we compare our matching based tests with other relevant
parametric tests. Finally, in Section 3.3 we present an extensive comparison of the empirical
power of the MCM and MCMM tests, across increasing dimensions (d) and group sizes (K).
Additional simulations are given in Appendix D. Throughout, the nominal level of the tests
are chosen to be 0.05.
3.1. Comparison with the MST. Here, we compare the performance of the optimal
matching based tests described above, with the test based on the MST. As in (2.4), a
natural extension of the 2-sample Friedman-Rafsky test based on the MST, is the multi-
sample Friedman-Rafsky test (MFRT), which rejects the null hypothesis for small values of
the statistic:
TK,N :=
∑
1≤s<t≤K
Ns∑
i=1
Nt∑
j=1
1{(X(s)i , X(t)j ) ∈ E(T (X ))}, (3.1)
where T (X ) is the minimum spanning tree of the pooled sampleX := {X(1),X(2), . . . ,X(K)}.
The MFRT, unlike the MCM and MMCM statistics, is not distribution-free under the null,
however, it can be easily calibrated as a permutation test. We compare the power of this
test with the MCM and the MMCM tests in the following two scenarios. All the tests are
calibrated using 500 permutations, and the empirical power is calculated over 500 iterations.
• Normal Location: Here, we consider the family {Nd(µ, I) : µ ∈ Rd}. Figure 2(a) shows
the empirical power of the MFRT, the MCM test, and the MCMM test, when K = 3
and the data consists of 100 samples each from Nd(0, I), Nd(0.3·1, I), and Nd(0.6·1, I),
respectively. Figure 2(b) shows the empirical power of tests when K = 4 and 100
samples each are drawn from Nd(0, I), Nd(0.25 ·1, I), Nd(0.5 ·1, I) and Nd(0.75 ·1, I),
respectively. In both cases, the dimension d varies from 2 to 2000.
• Spherical Normal Scale: Here, we consider the family {Nd(0, σ2I) : σ > 0}. Figure
2(c) shows the empirical power of the MFRT, the MCM test, and the MCMM test,
when K = 3 and the data consists of 100 samples each from Nd(0, I), Nd(0, 1.5 · I),
and Nd(0, 2 · I), respectively. Figure 2(d) shows the empirical power of tests when
K = 4 and 100 samples each are drawn from Nd(0, I), Nd(0, 1.25 · I), Nd(0, 1.5 · I)
and Nd(0, 1.75 · I), respectively. As before, the dimension d varies from 2 to 2000.
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Figure 2. Power of the different tests across increasing dimension in (a) the normal
location family with K = 3 groups, (b) the normal location family with K = 4 groups,
(c) the spherical normal scale family with K = 3 groups, and (d) the spherical normal
scale family with K = 4 groups.
The plots show that for location alternatives, the 3 tests have very similar power, with the
MFRT performing marginally better than the MCMM, which is marginally better than the
MCM. However, in the scale problem, the MCM and the MMCM tests drastically outperforms
the MFRT. Here the power of the MFRT goes down to zero as the dimension increases,
whereas the MCM and MCMM both have power improving with dimension and eventually
going up to 1, illustrating the benefits of the distribution-free property of optimal matchings
in high-dimensional problems.
3.2. Comparison with Parametric Tests. Here, we compare the performance of the
MCM and the MMCM tests with baseline parametric tests, for relatively low-dimensional
problems (where the corresponding parametric tests are applicable). As before, we consider
location and scale alternatives in the normal family. Here, use the asymptotic distributions
derived above to choose the cutoffs of the tests.
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Figure 3. Power of the different tests in the normal location family when the
number of classes (a) K = 7, and (b) K varying between 2 and 10.
Example 1. (Normal Location) Here, we compare the MCM and the MMCM tests with
the Anderson’s test for Gaussian location alternatives [2].5 As is common in parametric
tests, since Anderson’s statistic requires inverting certain sample covariance matrices, the
test, unlike the MCM and the MMCM, is inapplicable for large dimensions, specifically if
d ≥ NK(K−1) . When the dimension is much smaller than this threshold and there is a moderate
sample size, Anderson’s test performs well (this is expected because the test is specifically
designed for such alternatives). However, when the dimension increases and comes closer to
the boundary, Anderson’s test start to lose power. In fact, we see below that for dimensions
close to this threshold, that non-parametric matching based methods outperform Anderson’s
test, for relatively small sample sizes.
• Figure 3(a) shows the empirical power (over 500 iterations) of the Anderson’s test,
the MCM test, and the MCMM test, for K = 7 classes in dimension d = 16. The
horizontal axis shows the magnitude of separation ∆, and the data consists of 100
samples from each of the following 7 distributions: for 1 ≤ s ≤ 7, the s-th distribution
corresponds to N16((s− 1)∆ · 1, I). Each simulation was repeated for 6 values of ∆:
0.01, 0.03, 0.05, 0.07, 0.1, 0.15.
• Figure 3(b) shows the empirical power when we vary both the number of classes K
and the dimension d. Here, K varies from 2 to 10 (shown in the horizontal axis), and
for each K the dimension d is chosen just below the dimension threshold of Anderson’s
test, and the s-th distribution corresponds to Nd(
s−1
10 · 1, I), for 1 ≤ s ≤ K.
In both the cases, we observe that the power of the MCM and the MMCM tests are noticeably
better than that of Anderson’s test.
5This is a standard multisample method for testing difference of normal means. In the case where all the K
sample sizes are equal, the Anderson’s test constructs, a vector V (s) of length (K − 1)d formed by appending
K − 1 linearly independent contrasts based on the s-th observations from each of the K classes, for each
1 ≤ s ≤ N/K. Then the test statistic is based on a Hoteling’s T 2 statistic constructed from the vectors
V (1), . . . , V (N/K). The reader is referred to [2] for the precise description of this test.
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Example 2. (Normal Scale) Here, we compare the MCM and the MMCM test with the
likelihood ratio test (LRT) for the equality of covariance matrices, when the means are un-
known,6 in the Normal scale family. This test performs well for small dimensions, especially
when the sample sizes across the classes are equal. However, we see below that even in rela-
tively small dimensions, the LRT performs poorly when the sample sizes become unbalanced,
but the matching based tests continue to have significant power.
• Figure 4(a) shows the empirical power (over 500 iterations) of the LRT, the MCM
test, and the MCMM test, for K = 4 classes in dimension d = 20. The horizontal
axis shows the magnitude of separation ∆, and the data consists of 80, 95, 110 and
125 samples from the following 4 distributions: for 1 ≤ s ≤ 4, the s-th distribution
corresponds to N20 (0, (1 + (s− 1)∆)I). Each simulation was repeated for 10 values
of ∆: 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85.
• Figure 4(b) shows the empirical power (over 500 iterations) when we vary the sample
size difference δ among the classes from 8 to 18. The horizontal axis shows this
sample size difference δ. For each δ, the data consists of 80, 80+δ, 80+2δ and 80+3δ
samples from the the following 4 distributions respectively: for 1 ≤ s ≤ 4, the s-th
distribution corresponds to N20
(
0, s+12 I
)
.
In the first case, we observe that the power of all the tests increase to 1, but the MCM and
the MMCM tests dominate that of the LRT by a significant margin for smaller separations.
In the second case, however, with increase in the difference of sample size across the classes,
the power of the LRT decreases to 0, while the power of the MCM and MMCM tests remain
stable at high values, illustrating the robustness of these methods even for low-dimensional
problems.
3.3. Comparison between the MCM and the MMCM Tests. In this section, we com-
pare the finite-sample power of the MCM and the MMCM tests in various examples. Here, we
consider 3 distributional models: (1) the normal location family {Nd(µ, I) : µ ∈ Rd}, (2) the
spherical normal scale family {Nd(0, σ2I) : σ > 0}, and (3) the equi-correlated normal scale
family {Nd(0, (1− ρ)I) + ρ11> : 0 ≤ ρ < 1}. A typical simulation instance looks as follows.
We generate samples from K different d-dimensional distributions from an underlying dis-
tributional model. The difference between the K distributions is quantified by a separation
parameter ∆ (which depends on location parameter/spherical scale parameter/correlation
parameter, depending on the underlying distributional model). For each of the distributional
models we consider two scenarios: (1) the fixed class scenario where the number of classes
K is fixed and we perform a two-way power comparison with ∆ versus d, and (2) the fixed
dimension scenario, where we fix the dimension d, and perform a two-way power compar-
ison with ∆ versus K. In all the simulations, the power is calculated over 100 iterations.
Additional simulations, comparing the MCM and the MCMM tests, in the lognormal family
6In this case, the LRT statistic rejects for small values of λ = exp(− 1
2
∑K
i=1Ni log |S−1i S|), where Si is the
covariance matrix of the i-th sample, for 1 ≤ i ≤ K, and S is the pooled sample covariance matrix. Under the
null hypothesis of equality of covariance matrices, −2 log λ has an asymptotic chi-squared distribution with
1
2
d(d+ 1)(K − 1) degrees of freedom.
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Figure 4. Power of the different tests for the spherical normal scale problem for
(a) varying scale shift, and (b) varying difference in sample size
∆ ↓ Dimension 5 10 50 100 200 300 500
.04
MCM .26 .30 .16 .19 .36 .41 .57
MCMM .29 .44 .10 .17 .25 .44 .76
.06
MCM .43 .51 .31 .43 .41 .52 .92
MCMM .59 .69 .46 .32 .37 .70 1.0
.08
MCM .49 .61 .39 .48 .50 .85 1.0
MCMM .67 .81 .65 .64 .65 .99 1.0
.10
MCM .66 .70 .77 .60 .97 .99 1.0
MCMM .81 .84 .90 .79 .99 1.0 1.0
.12
MCM .81 .97 .81 .87 1.0 1.0 1.0
MCMM .94 1.0 .93 1.0 1.0 1.0 1.0
(a)
∆ ↓ Groups 4 6 8 10
.04
MCM .06 .42 .45 .80
MCMM .04 .53 .78 .97
.05
MCM .11 .61 .85 1.0
MCMM .07 .78 .99 1.0
.07
MCM .19 .77 1.0 1.0
MCMM .13 0.96 1.0 1.0
.09
MCM .47 .93 1.0 1.0
MCMM .53 1.0 1.0 1.0
.10
MCM .55 1.0 1.0 1.0
MCMM .70 1.0 1.0 1.0
(b)
Table 1. Power of the MCM and the MMCM tests in the normal location family
with (a) the number of classes K = 6 fixed, and (b) the dimension d = 150 fixed.
(The higher power in each case is in bold.)
are given in Appendix D. Overall, we observe that MCM and MCMM tests are compara-
ble for small dimension and group sizes, but the MCMM test outperforms the MCM as the
dimension, groups, or separation increases.
• Normal Location: Here, we consider samples from the following K distributions:
Nd((s− 1)∆1, I), for 1 ≤ s ≤ K. Table 1(a) shows the fixed class scenario, where we
take K = 6 groups and vary the dimension d from 5 to 500, and ∆ from 0.04 to 0.12.
Table 1(b) shows the fixed dimension scenario, where the dimension d = 150 is fixed,
the number of groups K varies along 4, 6, 8, 10, and ∆ varies from 0.04 to 0.10. In
both cases, the sample sizes were taken in equal increments of 50, starting from 50.
• Spherical Normal Scale: Here, we consider samples from the following K distributions:
Nd(0, (1 + (s− 1)∆)I), for 1 ≤ s ≤ K. Table 2(a) shows the fixed class scenario, with
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K = 6 and dimension d varying from 5 to 500, and ∆ varying from 0.05 to 0.4. Table
2(b) shows the fixed dimension scenario, where the d = 150 is fixed, and K varies
along 4, 6, 8, 10, and ∆ varies from 0.05 to 0.4. As before, in both cases, the sample
sizes were taken in equal increments of 50, starting from 50.
∆ ↓ Dimension 5 10 50 100 200 300 500
.15
MCM .12 .16 .22 .33 .51 .55 .71
MMCM .06 .13 .28 .37 .67 .86 .92
.20
MCM .13 .24 .41 .46 .68 .79 .94
MMCM .12 .19 .59 .78 .95 .99 1.0
.25
MCM .21 .31 .47 .60 .81 .88 1.0
MMCM .23 .38 .85 .98 1.0 1.0 1.0
.30
MCM .22 .43 .70 .91 .98 1.0 1.0
MMCM .25 .53 .99 1.0 1.0 1.0 1.0
.35
MCM .24 .38 .75 .87 1.0 1.0 1.0
MMCM .30 .54 .99 1.0 1.0 1.0 1.0
.40
MCM .29 .50 .86 1.0 1.0 1.0 1.0
MMCM .49 .85 1.0 1.0 1.0 1.0 1.0
(a)
∆ ↓ Groups 4 6 8 10
.15
MCM .27 .68 .91 1.0
MMCM .18 .91 1.0 1.0
.20
MCM .48 .89 .99 1.0
MMCM .48 1.0 1.0 1.0
.25
MCM .66 .96 1.0 1.0
MMCM .89 1.0 1.0 1.0
.30
MCM .87 1.0 1.0 1.0
MMCM .98 1.0 1.0 1.0
.35
MCM .95 1.0 1.0 1.0
MMCM 1.0 1.0 1.0 1.0
.40
MCM 1.0 1.0 1.0 1.0
MMCM 1.0 1.0 1.0 1.0
(b)
Table 2. Power of the MCM and the MMCM tests in the spherical normal scale
family with (a) the number of classes K = 6 fixed, and (b) the dimension d = 150
fixed.
• Equi-correlated Normal Scale: Here, we consider samples from the following K distri-
butions: Nd(0, (1−ρs)I +ρs11>), where ρs := (s− 1) ∆K−1 , for 1 ≤ s ≤ K. Table 3(a)
shows the fixed class scenario, with K = 6 and dimension d varying from 5 to 500,
and ∆ varying from 0.15 to 0.4. The sample sizes are taken to be 50, 100, 150, 200, 250
and 300. Table 3(b) shows the fixed dimension scenario, where the d = 150 is fixed,
and K varies along 4, 6, 8, 10, and ∆ varies from 0.15 to 0.4, as before. The sample
sizes are taken in equal increments from 50 to 200 when K = 4, from 50 to 300 when
K = 6, from 50 to 260 when K = 8, and from 50 to 230 when K = 10.
In all the simulations above (and those in Appendix D), we observe that the power of
both the MCM and the MMCM tests improve with increasing separation and dimension. For
smaller dimensions and separations, the power of both the tests are comparable, however, the
MCMM test quickly gains power and performs noticeably better than the MCM, for higher
dimensions and larger separations. This leads to our preference for using the MMCM over
the MCM especially in high dimensions, which is often the case for real life datasets.
4. Distribution Under the Alternative
In this section we will prove a central limit theorem for the vector of cross-counts, and,
as a corollary, derive the asymptotic distribution of the cross-match (2.1), the MCM (2.4)
and MMCM (2.5) statistics, under general alternatives. We begin with an alternative way to
describe the joint distribution of the data {X(1),X(2), . . . ,X(K)}:
16 AGARWAL, MUKHERJEE, BHATTACHARYA, ZHANG
∆ ↓ Dimension 5 10 50 100 200 300 500
.15
MCM .10 .11 .16 .22 .34 .38 .35
MMCM .08 .11 .19 .27 .36 .37 .39
.20
MCM .07 .10 .17 .24 .25 .35 .43
MMCM .06 .09 .15 .25 .38 .49 .64
.25
MCM .09 .16 .25 .27 .39 .44 .50
MMCM .02 .09 .29 .42 .55 .66 .78
.30
MCM .08 .17 .27 .32 .56 .67 .71
MMCM .14 .13 .36 .48 .78 .79 .93
.35
MCM .12 .19 .45 .46 .60 .65 .88
MMCM .06 .15 .50 .70 .81 .90 .99
.40
MCM .15 .26 .51 .70 .77 .84 .95
MMCM .12 .26 .70 .91 .98 1.0 1.0
(a)
∆ ↓ Groups 4 6 8 10
.15
MCM .26 .19 .29 .31
MMCM .20 .26 .32 .34
.20
MCM .43 .30 .29 .18
MMCM .37 .35 .42 .26
.25
MCM .48 .40 .34 .32
MMCM .54 .47 .43 .28
.30
MCM .61 .53 .43 .28
MMCM .59 .63 .58 .47
.35
MCM .66 .63 .47 .43
MMCM .78 .80 .76 .71
.40
MCM .87 .72 .67 .57
MMCM .99 .95 .90 .83
(b)
Table 3. Power of the MCM and the MMCM tests in the equi-correlated normal
scale family with (a) the number of classes K = 6 fixed, and (b) the dimension
d = 150 fixed.
• Let Z1, Z2, . . . , ZN be i.i.d. from the density φN :=
∑K
s=1
Ns
N fs in R
d, where f1, f2, . . . , fK
are the densities (with respect to the Lebesgue measure on Rd) of the distributions
F1, F2, . . . , FK , respectively.
• Given ZN = (Z1, Z2, . . . , ZN ), assign a random label Lj ∈ [K] := {1, 2, . . . ,K} to Zj ,
independently for each 1 ≤ j ≤ N , where
P(Lj = s|Zj) =
Ns
N fs(Zj)
φN (Zj)
, for all s ∈ [K]. (4.1)
• Denote by ηs :=
∑N
i=1 1{Li = s}, the number of elements labelled s. Then it is easy to
verify that the joint distribution of ({Zj : Lj = 1}, {Zj : Lj = 2}, . . . , {Zj : Lj = K})
conditional on (η1, · · · , ηK) = (N1, N2, . . . , NK) is same as the joint distribution of
the data
(
X(1),X(2), . . . ,X(K)
)
(see Lemma B.1).7
It is also often convenient (because of the independence of the labelings) to work with un-
conditional distribution of ({Zj : Lj = 1}, {Zj : Lj = 2}, . . . , {Zj : Lj = K}), which we will
refer to as the bootstrap alternative distribution.
Now, define the K ×K matrix BN = (bst)1≤s,t≤K as follows:
bst =

∑
1≤i 6=j≤N e(Zi, Zj)1{Li = s, Lj = t} if s 6= t,
1
2
∑
1≤i 6=j≤N e(Zi, Zj)1{Li = Lj = s} if s = t.
(4.2)
where e(x, y) := 1 {(x, y) ∈ E(G (ZN ∪ {x, y}))}. Moreover, for notational convenience, de-
note η := (η1, . . . , ηK) and N := (N1, . . . , NK). Then, for 1 ≤ s, t ≤ K the cross/pure counts
7Note that under the null, (4.1) simplifies to P (Lj = s|Zj) = NsN , and the procedure described above, is
precisely the way to generate the permutation null distribution.
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ast (recall (2.2) and (2.3)) can be re-written in terms of the ZN and the labelings as follows:
ast
D
= bst
∣∣∣{η = N}, (4.3)
Therefore, the conditional mean of the pure/cross-counts under the bootstrap alternative
distribution is
νN (s, t) := EH1(bst|ZN ) =

∑
1≤i 6=j≤N e(Zi, Zj)h
(N)
st (Zi, Zj), if s 6= t
1
2
∑
1≤i 6=j≤N e(Zi, Zj)h
(N)
ss (Zi, Zj), if s = t,
(4.4)
where h
(N)
st (x, y) =
Ns
N
Nt
N
fs(x)ft(y)
φN (x)φN (y)
. We denote the matrix of these conditional expectations
by µN = ((µN (s, t)))1≤s,t≤K . Note the expressions in the RHS above is permutation invariant
and a function of the pooled sample (forgetting the labels). For example, for s 6= t,
νN (s, t)
∣∣∣{η = N} D= ∑
1≤a,b≤K
Na∑
i=1
Nb∑
j=1
h
(N)
st (X
(a)
i , X
(b)
j )e(X
(a)
i , X
(b)
j ) =: µN (s, t), (4.5)
which can be computed from the pooled data at a known alternative point (f1, f2, . . . , fK).
As usual, denote by µ
N
the vector obtained by concatenating the rows of the matrices
µN := ((µN (s, t))) in the upper triangular part. Note that µN can be thought of as the
conditional mean of the vector AN given the pooled sample, where the randomness comes
only from the labeling of the classes.
In the theorem below we show that the vector AN (recall that this is the vector obtained
by concatenating the rows of AN in the upper triangular part, as defined in (2.5)) centered
by the corresponding vector of conditional means µ
N
and scaled appropriately, converges in
distribution to a
(
K
2
)
-dimensional multivariate normal in the usual asymptotic regime (2.8).
The proof of the theorem is given in Appendix B.
Theorem 4.1. Under general alternatives, in the usual asymptotic regime (2.8),
AN − µN√
N
D−→ N(K2 )(0,Γf1,f2,...,fk), (4.6)
where the covariance matrix Γf1,f2,...,fk is as in Definition B.1 (in Appendix B).
The joint normality of the vector AN implies the normality of linear functions of AN ,
in particular the MCM statistic (recall (2.4)), which can be re-written as RK,N = 1
>AN .
Therefore,
RK,N − 1>µN√
N
D−→ N(K2 )(0,1
>Γf1,f2,...,fK1).
Similarly, for the MMCT statistic, (4.6) implies
(AN − µN )>Γ−1f1,f2,...,fK (AN − µN )
N
D−→ χ2
(K2 )
.
Even though the general expression for the covariance matrix Γf1,f2,...,fk (Definition B.1 in
Appendix B) can be complicated, it simplifies nicely for the case K = 2. To this end, recall
the 2-sample cross match statistic R2,N from (2.1). Let X denote the pooled sample. Then,
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by (4.5),
EH1(R2,N |X ) =
∑
1≤a,b≤2
Na∑
i=1
Nb∑
j=1
N1
N
N2
N
f1(X
(a)
i )f2(X
(b)
i )
φN (X
(a)
i )φN (X
(b)
i )
e(X
(a)
i , X
(b)
j ). (4.7)
We now have the following result for the 2-sample cross match test, which is a straightforward
calculation from (4.6) above.
(a) (b)
Figure 5. Histogram of the centered CM statistic (over 1000 iterations) and the
predicted normal density (the red curve) when (a) f1 = N10(0, I) and f2 = N10(1, I)
(normal location alternatives) and (b) f1 = N10(0, I) and f2 = N10(0, 2I) (normal
scale alternatives).
Corollary 4.2. For 2-sample cross match statistic R2,N as in (2.1), as N →∞,
R2,N − EH1(R2,N |X )√
N
D−→ N(0, γ2f1,f2),
where EH1(R2,N |X ) is as in (4.7) and
γ2f1,f2 := p1p2
{ˆ
f1(z)f2(z)(p
2
1f
2
1 (z) + p
2
2f
2
2 (z))
φ(z)3
dz −
(ˆ
f1(z)f2(z)(p2f2(z)− p1f1(z))
φ(z)2
dz
)2}
,
with φ := p1f1 + p2f2.
The results above add to our mathematical understanding of the alternative properties of
matching-based tests, which up till now have been largely unexplored. Figure 5 shows the
histogram of the centered CM statistic computed using 600 samples from one distribution
and 400 samples from another, repeated over 10000 iterations, for normal location and scale
alternatives, and density of the corresponding limiting normal distribution (the red curve),
as predicted by corollary above. The plots validate the asymptotic results and show that the
normal approximation is quite accurate even for moderate sample sizes.
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5. Application to Single Cell RNA Sequencing Data
In this section we apply the tests described above to single cell transcriptomics data ob-
tained from the peripheral blood, cancer tissue and tumor-adjacent normal tissue of human
subjects with hepatocellular carcinoma and non-small-cell lung cancer. Our goal is to in-
vestigate how biochemical metabolic pathways change across immune cells in a cancer en-
vironment, depending on the location of the tissue. We begin with a short background on
biological pathways and the single cell RNA sequencing data.
Every tissue in the human body comprises of numerous different cell types, and each cell in
turn contains tens of thousands of genes. The function of a tissue or an organ is rarely driven
by a single unique gene, and analogously, complex disorders of organ dysfunction affect mul-
tiple genes. Therefore, to understand complex diseases, a systems biology approach examines
sets or functional modules of related genes, called biological pathways. Because diseases such
as cancer result from different combinations of perturbed gene activities, grouping genes into
functional sets can often provide deeper insights into the underlying biological system. In-
deed, the activity of certain pathways, particularly those that regulate cellular metabolism,
has been found to be a strong predictor of complex phenotypes and response to treatment,
both at the level of cells as well as that of individual patients [1, 12].
A biological pathway can be defined as a collection of molecules that coordinate to perform
a specific action or change in the cell. This change could involve production of a new molecule,
movement, growth or a physical transformation, or even cell death. While the activity of a
particular pathway can be understood qualitatively based on the phenotypic changes in a
cell, its quantitative estimation relies on the relative proportion of RNA molecules produced.
The use of gene expression as a proxy for activity rests on the notion that the amount of
mRNA molecules produced represent the economic resources of the cell [27]. Despite an
understanding of how individual molecules in a biological pathway orchestrate a particular
cellular function, it remains unclear whether the distribution of certain gene modules, and by
proxy the corresponding pathway activities, are shared across cell types [35]. It has recently
been shown that vastly different cell types contain similar ratios of metabolic enzymes, and
tightly control the amounts of specialized proteins produced [26], highlighting previously
unappreciated similarities among cell types. Nonetheless, the extent to which the distribution
of relative mRNA molecules for genes in a given pathway might be consistent across different
cell types remains elusive. Are there certain pathways which maintain a similar activity
across cell types? This question is of fundamental significance because if true, it suggests a
widespread design principle of cell biology.
With the advent of single cell RNA sequencing, it is now possible to study distinct but
closely related cell populations [46] and examine the aforementioned question. Single cell
RNA-sequencing (scRNA-seq) allows us to measure gene expression information from tens of
thousands of individual cells, unraveling the cellular heterogeneity of a tissue in unprecedented
detail. The resulting data can be thought of as a c× g matrix, η = ((ηab))1≤a≤c,1≤b≤g, where
c corresponds to the number of cells, and g refers to the number of genes, and each entry
ηab corresponds to the number of RNA molecules detected for a given gene a in some cell b.
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The high-dimensional, multisample (corresponding to multiple cell-types) nature of a typical
scRNA-seq experiment makes this a fitting application of the multi-sample crossmatch test.
5.1. Data Overview and Study Setup. We apply our method on scRNA-seq data gen-
erated from purified T cell populations found in three tissue locations: (a) peripheral blood
(hereafter referred to as blood), (b) tumor-infiltrating immune cells (hereafter referred to as
tumor), and (c) normal tissue adjacent to the tumor from the same organ (hereafter referred
to as adj. normal). We examined the following two datasets, where T cells extracted from
each location were assigned a particular subtype based on flow cytometry and expression of
known canonical cell surface proteins.8
(1) Non-Small-Cell Lung Cancer (NSCLC [17]) dataset: Here, the T cell subtypes found
at each location were: CD8+ Cytotoxic, CD4+ Naive, CD4+ Regulatory T cells
(denoted by Treg), and CD4
+ Naive Helper.
(2) Hepatocellular Carcinoma (HCC [47]) dataset: Here, the T cell subtypes profiled were:
CD8+ Cytotoxic, CD4+ Naive, and CD4+ Regulatory T cells (Treg).
Recall that single cell data is extremely sparse count data with complex correlation struc-
ture. Nonetheless, the two datasets are comparable in terms of the sequencing protocol used,
data generation, and the technical quality of the data (Table 4). In both the datasets we used
deep sequencing was performed, ensuring our ability to detect genes with low expression. The
summary of the number of cells sequenced for each cell type is provided in Table 5.
NSCLC HCC
Mean reads per cell 1,040,000 1,100,000
Median genes per cell 2,859 2,702
Total number of T cells profiled 12,210 4,794
Table 4. Summary characteristics of the two scRNA-seq datasets: Non-Small-Cell
Lung Cancer (NSCLC) and Hepatocellular Carcinoma (HCC). For scRNA-seq it has
been shown that with half a million reads per cell, most genes expressed can be
detected, and that one million reads are sufficient to estimate the mean and variance
of gene expression [38].
The metabolic state of T cells is implicated in diseases such as cancer, wherein the tumor
microenvironment enforces dysfunctional T cell metabolism, thereby negatively affecting their
anticancer functionality [4]. Thus, for each of the two cancer datasets and in the three tissue
locations described above (namely, Adj. Normal, Tumor, and Blood), we examine whether
the distribution of gene sets that correspond to biological metabolic pathways are consistent
across T cell subtypes (therefore, the number of different T cell subtypes corresponds to the
number of classes K). We specifically focus on 86 metabolic pathways described in the Kyoto
Encyclopedia of Genes and Genomes (KEGG [23]). We obtained a list of genes corresponding
to each pathway, and subsequently ascribed genes into 86 subsets, each subset corresponding
8Both the datasets used are open access, and available in the Gene Expression Omnibus (GEO). The raw
sequencing data for T cells for the Hepatocellular Carcinoma dataset can be obtained from the GEO entry
GSE98638 and the European Genome-phenome Archive database entry EGAS00001002072. The single cell
sequencing data corresponding to the Non-Small-Cell Lung cancer case study can be found at GSE99254 and
EGAS00001002430.
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Non-small-cell Lung Cancer (K = 4 groups)
Tissue Type CD8+ Cytotoxic CD4+ Naive CD4+ Treg CD4
+ Helper
Adj. Normal (2115 cells) 934 655 288 238
Tumor (5835 cells) 2182 1591 1170 892
Blood (4260 cells) 1323 1254 1011 672
Hepatocellular Carcinoma (K = 3 groups)
Tissue Type CD8+ Cytotoxic CD4+ Naive CD4+ Treg
Adj. Normal (997 cells) 412 406 179
Tumor (2170 cells) 563 515 549
Blood (1627 cells) 777 606 787
Table 5. The number of cells sequenced for various T cell subtypes in each of the
two cancer settings. These correspond to the sample sizes of the different groups
in the K-sample hypothesis testing problem. (Adj. Normal denotes tumor-adjacent
normal tissue from the same organ, Treg stands for regulatory T cell, and CD ab-
breviates cluster of differentiation or classification determinant, a protocol used for
immunophenotyping cells.)
to a metabolic pathway. Then, for each one of the 3 different tissue locations and for each
one of the 86 pathways, we tested the null hypothesis (using the MCMM test (2.5) described
above) that the multivariate distribution of the genes belonging to that particular pathway
is alike across the K different T cell subtypes (recall that K = 4 in the Non-Small-Cell Lung
Cancer dataset, and K = 3 in the Hepatocellular Carcinoma dataset). In each of the cases the
corresponding sample sizes for the K groups are given in the rows of Table 5. The number of
genes in a given metabolic pathway ranged approximately between 30 and 110. To account for
multiple-hypothesis testing, the resulting p-values are adjusted using the Benjamini-Hochberg
(BH) correction procedure [5].
This study design allowed us to understand which metabolic pathways change in dis-
tribution across distinct, but closely-related, T cell subtypes. In particular, assessing the
distribution of gene sets that belong to a particular metabolic pathway across the T cell
subtypes allows us to address the following questions: (1) Which pathways have a similar
distribution across T cell subtypes in a given tissue? (2) Are there pathways that have a
stable and comparable distribution across T cell subtypes in a normal/healthy tissue, but a
heterogenous or perturbed distribution in a tumor? (3) For pathways that have a disparate
distribution across the T cell subtypes, which subtypes show the most distinct distribution?
5.2. Comparing Pathway Distributions Based on Tissue Location. The following is
the outcome of the BH-corrected MCMM tests for assesing metabolic pathway distributions
across the different T cell subtypes in the two datasets:
• In the NSCLC dataset, we found that of the 86 pathways examined, our test did not
reject the null hypothesis for merely 35 pathways in the Tumor tissue, compared to
56 and 74 pathways in the Blood and Adj. Normal tissues, respectively.
• In HCC dataset, the set of pathways for which we failed to reject the null were
remarkably alike to that for NSCLC. Specifically, 41, 63 and 76 metabolic pathways
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were undistinguishable across T cell subtypes in the Tumor, Blood and Adj. Normal
tissues, respectively.
The fact that majority of the metabolic pathways do not show evidence for dissimilar
distribution across cell types based on our test indicates that the T cell subtypes might be
more similar than previously appreciated in terms of how they regulate their basic metabolic
machinery. Further, for each pair of tissue location, we computed the overlap in the pathways
for which the null hypothesis was accepted or rejected. As expected, we found that the
concordance between the results was substantially higher for Blood and Adj. Normal, than
either of these tissues had with the Tumor tissue (this is seen from the off-diagonal values in
the tables in Figure 6).
0 1
0 59 4
1 17 6
0 1
0 40 1
1 36 9T
u
m
o
r0 1
0 38 25
1 3 20
Tumor 
0 1
0 53 3
1 21 9
0 1
0 34 1
1 40 11
Adj. Normal 
T
u
m
o
r0 1
0 33 23
1 2 28
Tumor 
B
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d
Non-small-cell Lung Cancer
0: Pathway distribution similar across T cell subtypes; 1: Pathway distribution perturbed across T cell subtypes
B
lo
o
d
B
lo
o
d
B
lo
o
d
Adj. Normal 
Adj. Normal Adj. Normal 
Hepatocellular Carcinoma
Figure 6. A set of 2 × 2 tables showing how many of the 86 hypothesis (cor-
responding to the pathways) were accepted/rejected for each of 3 pairs of tissue
locations. Here, 0 stands for pathways whose distribution are either similar/stable
(null hypothesis accepted), and 1 stands for pathways whose distributions are per-
turbed/heterogenous (null hypothesis rejected), across the T cell subtypes in two
types of solid organ malignancies.
Interestingly, we found that 8 metabolic pathways were differentially distributed across the
T cell subtypes in each tissue examined in NSCLC whereas 5 pathways exhibited this pattern
in the HCC dataset (Figure 7). The purine metabolism pathway was a common pathway
shared by both datasets which showed evidence for heterogenous distribution among the T
cell subtypes in every tissue. This discovery suggests that purine metabolism is fundamentally
different even among the closely related T cell subtypes. In order to find out which T cell
subtype contributed most to this difference for the metabolic pathways that emerged as being
heterogeneously distributed in all tissues, we employed a class selection procedure described
below. To select a single class, we looked at all the pairwise comparisons where the null
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was rejected, and then identified the class that was common across all the cases of rejection
(Figure 7c-d).
We found that CD4+ regulatory T cells (Tregs) were the strongest contributors as to
why a pathway, such as purine metabolism, was detected as being differentially distributed.
It is important to note that, purine metabolism regulates the balance of proinflammatory
and immunosuppressive molecules produced by T cells, and the activation of the purinergic
receptor P2X7 has been shown to inhibit the immunosuppressive functions specifically in
Tregs [40]. Thus, the fact that our test discovered purine metabolism as being differentially
distributed across T cell subtypes in both studies, and specifically in Tregs, showcases its
ability to unearth meaningful biological phenomena.
Figure 7. (a), (b) Venn diagrams showing the overlap among the metabolic path-
ways that demonstrated evidence for differential and similar distributions across the
T cell subtypes in NSCLC and HCC, respectively. For the pathways that were het-
erogenous among the T cell classes across all 3 tissue types, we used the class selection
procedure to identify which T cell subtype had the most disparate distribution (c),
(d). Differential distribution for the purine metabolism pathway, driven largely by
Tregs, was observed in both NSCLC and HCC.
5.3. Differentially Distributed Pathways as Biological and Algorithmic Features.
In the NSCLC dataset, we found that 51 pathways showed evidence for differential distribu-
tion across the tumor-infiltrating T cell subtypes, whereas 45 pathways exhibited this pattern
in the tumor-infiltrating T cells in the HCC dataset. We observed that if a metabolic path-
way demonstrated an intra-T cell-type heterogenous distribution in Blood and Adj. Normal,
that heterogeneity was preserved in the Tumor tissue (in the first and third Venn diagrams
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in Figure 7, the intersection of the green (Adj. Normal) and the blue circles (Blood) is com-
pletely contained in the orange circle corresponding to Tumor). In other words, rejecting the
null for a particular pathway for T cells in the Adj. Normal and Blood tissues was useful
in prognosticating that pathway’s behavior in the tumor-infiltrating T cells. On the other
hand, we found that certain pathways that demonstrated a dissimilar distribution across T
cell subtypes in the Tumor and Adj. Normal tissues showed evidence for homogenous distri-
bution in blood (the intersection of the green and orange circles minus the blue circle in the
first and third Venn diagrams in Figure 7). Specifically, this pattern was true for 2 pathways
(sphingolipid metabolism and glycophospholipid synthesis) in the NSCLC dataset, and for 3
pathways (phenylalanine metabolism, oxidative phosphorylation and O-glycan biosynthesis)
in the HCC dataset. This difference can be attributed, at least partially, to the organ-specific
function of these pathways. For instance, ceramide, a central molecule in the sphingolipid
metabolism, regulates endothelial permeability and airway smooth muscle function in the
lungs [43], and increased sphingolipid metabolism is a hallmark of lung cancer [34]. Simi-
larly, phenylalanine hydroxylase, the main enzyme in the phenylalanine metabolism pathway
is active exclusively in the liver [30], and otherwise inactive in the blood. Hence, in light of
the organ-specific roles of these pathways, it is rather reassuring that our test appropriately
rejects the null hypothesis and captures their heterogenous distribution among the T cell
subtypes based on the tissue location.
Clustering and cell type identification are crucial steps in single cell data analysis. scRNA-
seq analysis pipelines often first identify highly variable genes in the dataset, and subsequently
use those genes as an input to the t-distributed stochastic neighbor embedding (tSNE) algo-
rithm. Even with this approach, however, single cell analysis pipelines typically fail to resolve
the different T cell populations, and rarely identify the different immune cell subtypes in any
reliable or discrete fashion. We wondered whether in practice, one might be able to utilize our
test to identify differentially distributed pathways and then use this information to improve
the tSNE-based clustering approach. To investigate whether the pathways that emerge as
being differentially distributed can serve as meaningful features in identifying cell types, we
focussed on the pathways that were consistently identified as being differentially distributed
across the T cells in all three tissue types in NSCLC. To our surprise, we found that using the
subset of genes corresponding to the pathways that our analysis identified as being hetero-
geneously distributed improves the clustering results (Figure 8(a)). Moreover, the clustering
results converge with, and act as an indirect validation for our class selection approach be-
cause the latter identified CD4+ Tregs as the cell type with the dissimilar distribution for
metabolic pathways such as IP3 metabolism, purine metabolism, and arginine and proline
metabolism. When we used the genes comprising these pathways as the input to tSNE (Fig.
8a), we observed that indeed the CD4+ Tregs became more easily visually distinguishable
compared to using the genes in other pathways which had a similar distribution across the
T cell subtypes (Figure 8(b)).
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Figure 8. Results of the tSNE analysis performed using a specific pathway to
cluster the 4 different tumor-infiltrating T cell subtypes in NSCLC: (a) pathways that
were identified as differentially distributed successfully manage to segregate CD4+
Tregs as predicted by our class selection procedure, whereas (b) pathways that were
identified as being similar across the T cell subtypes produce a more patchy clustering
wherein the subtypes are visually indistinguishable. All tSNE plots were generated
with perplexity = 30.
6. Discussion
This paper introduces a novel graph-based nonparametric test for comparing multiple
multivariate distributions. Using optimal matching as the basis, we demonstrate that our
test, in addition to other multisample generalizations of Rosenbaum’s crossmatch test [39],
is distribution-free, computationally efficient, and consistent for general alternatives, making
it particularly attractive for modern high-dimensional statistical applications. We also ob-
tain a joint central limit theorem for the entire matrix of cross-counts, and, hence, derive a
distributional limit theorem for the test statistics, under general alternatives. Our numer-
ical experiments demonstrate that the proposed method outperforms other non-parametric
graph-based multisample methods as well as commonly used parametric tests, in a variety
of simulation settings. Lastly, we showcase the utility of this test in the field of single cell
transcriptomics where we used our test to address an important question in signal trans-
duction and cell biology. Our multisample procedure uncovered revealing patterns about
how closely-related, key immune cells in the body (namely, T cell subtypes), might alter
their metabolic machinery in solid organ malignancies, particularly depending on the tissue
location. We envision that this test and the underlying theoretical intuitions described in
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this work will find broad applicability in future research that examines hypothesis testing in
the multisample, multivariate framework. Furthermore, our test opens up new paradigms of
investigation for practitioners to assess its properties and its feasibility in being adapted to
other algorithms, as we have demonstrated here through its usage as a pre-processing step in
tSNE-based data visualization.
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Appendix A. Proofs from Section 2
In this section we present the proofs of the results from Section 2. The proof of Proposition
2.2, which computes the mean and the variance of AN is given in Section A.1. The proof of
the asymptotic null distribution in Theorem 2.3 is described in Section A.2, and the proof of
the consistency (Theorem 2.4) is in Section A.3.
A.1. Proof of Proposition 2.2. Since the conditional distribution of AN given X equals
the unconditonal distribution ofAN under the null, we can assume that the edges of G (X ) are
fixed, say {(1, 2), (3, 4), . . . , (N−1, N)} without loss of generality. For notational convenience,
let us define η := (η1, . . . , ηK) and N := (N1, . . . , NK). Following the notations in subsection
A.2, it follows that:
EH0(ast) =
I∑
j=1
PH0
({L2j−1, L2j} = {s, t}∣∣η = N) . (A.1)
By an easy sampling without replacement argument, for each j ≤ I,
PH0
({L2j−1, L2j} = {s, t}∣∣η = N) =

2NsNt
N(N−1) if s < t,
Ns(Ns−1)
N(N−1) if s = t.
The result in (2.7) now follows from (A.1) on observing that I = N/2.
Next, note that for 1 ≤ s1 6= s2 ≤ K,
VarH0(as1s2) =
I∑
j=1
VarH0
(
1 {{L2j−1, L2j} = {s1, s2}}
∣∣η = N)
+
∑
j1 6=j2
CovH0
(
1 {{L2j1−1, L2j1} = {s1, s2}} ,1 {{L2j2−1, L2j2} = {s1, s2}}
∣∣η = N) .
First, note that
I∑
j=1
VarH0
(
1 {{L2j−1, L2j} = {s1, s2}}
∣∣η = N) = I [ 2Ns1Ns2
N(N − 1)
] [
1− 2Ns1Ns2
N(N − 1)
]
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=
Ns1Ns2
N − 1
[
1− 2Ns1Ns2
N(N − 1)
]
. (A.2)
Next, we have∑
j1 6=j2
CovH0
(
1 {{L2j1−1, L2j1} = {s1, s2}} ,1 {{L2j2−1, L2j2} = {s1, s2}}
∣∣η = N)
=
∑
j1 6=j2
PH0
({L2j1−1, L2j1} = {L2j2−1, L2j2} = {s1, s2}∣∣η = N)− ∑
j1 6=j2
(
2Ns1Ns2
N(N − 1)
)2
= I(I − 1)4Ns1Ns2(Ns1 − 1)(Ns2 − 1)
N(N − 1)(N − 2)(N − 3) − I(I − 1)
(
2Ns1Ns2
N(N − 1)
)2
=
Ns1Ns2(Ns1 − 1)(Ns2 − 1)
(N − 1)(N − 3) −
Ns1Ns2
N − 1
[
Ns1Ns2
N − 1 −
2Ns1Ns2
N(N − 1)
]
(A.3)
Adding (A.2) and (A.3) gives the expression for VarH0(as1s2) given in Proposition 2.2. Next,
take 1 ≤ s1 6= s2 6= s3 ≤ K. Then,
EH0 (as1s2as1s3) =
∑
j1 6=j2
PH0
({L2j1−1, L2j1} = {s1, s2}, {L2j2−1, L2j2} = {s1, s3}∣∣η = N)
= I(I − 1) 4Ns1(Ns1 − 1)Ns2Ns3
N(N − 1)(N − 2)(N − 3)
=
Ns1(Ns1 − 1)Ns2Ns3
(N − 1)(N − 3) . (A.4)
The expression for CovH0(as1s2 , ss1,s3) now follows from (A.4) on observing that:
(EH0as1s2) (EH0as1s3) =
N2s1Ns2Ns3
(N − 1)2 .
Finally, take 1 ≤ s1 6= s2 6= s3 6= s4 ≤ K. In this case,
EH0 (as1s2as3s4) =
∑
j1 6=j2
PH0
({L2j1−1, L2j1} = {s1, s2}, {L2j2−1, L2j2} = {s3, s4}∣∣η = N)
= I(I − 1) 4Ns1Ns2Ns3Ns4
N(N − 1)(N − 2)(N − 3)
=
Ns1Ns2Ns3Ns4
(N − 1)(N − 3) . (A.5)
The expression for CovH0(as1s2 , ss3,s4) now follows from (A.5) on observing that:
(EH0as1s2) (EH0as3s4) =
Ns1Ns2Ns3Ns4
(N − 1)2 .
This completes the proof of Proposition 2.2. 
A.2. Proof of Theorem 2.3. Note that it suffices to prove (2.9). The remaining assertions
in Theorem 2.3 is an immediate consequence of (2.9). The proof of (2.9) proceeds in two-
steps: (1) 1√
N
(AN −EH0(AN )) D→ N(0,Γ), for some non-negative definite matrix Γ, and (2)
1
N CovH0(AN )→ Γ, and Γ is invertible.
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We begin with the proof of (1): Denote the pooled sample
X = (X
(1)
1 , . . . , X
(1)
N1
, . . . , X
(K)
1 , . . . , X
(K)
NK
)
(forgetting the labels) as ZN := (Z1, Z2, . . . , ZN ). Under the null H0, Z1, Z2, . . . , ZN are i.i.d.
F (the unknown null distribution). Let L1, . . . , LN be i.i.d. random variables, taking value
in {1, 2, . . . ,K}, independent of Z1, . . . , ZN , such that
P(L1 = s) =
Ns
N
, for all s ∈ [K]. (A.6)
For each s ∈ [K], define ηs =
∑N
i=1 1{Li = s} ∼ Bin(N, NsN ) and for each x, y ∈ Rd, let
e(x, y) := 1 {(x, y) ∈ E(G (ZN ∪ {x, y}))}. Define the K × K matrix BN = (bst)1≤s,t≤K as
follows:
bst =

∑
1≤i 6=j≤N e(Zi, Zj)1{Li = s, Lj = t} if s 6= t,
1
2
∑
1≤i 6=j≤N e(Zi, Zj)1{Li = Lj = s} if s = t.
UnderH0, it follows from Lemma B.1 that the conditional distribution ofBN given (η1, . . . , ηK) =
(N1, . . . , NK) is same as the distribution of AN . Therefore, it suffices to derive the limiting
distribution of BN |{(η1, . . . , ηK) = (N1, . . . , NK)}.
To this end, note that conditional on ZN , the matching graph G (ZN ) is fixed and since
the I = N/2 matched edges in the graph are disjoint, the samples in ZN can be (re)-
labelled 1, 2, . . . , N such that {(1, 2), (3, 4), . . . , (N − 1, N)} are the I matched edges. Then
the elements of the matrix BN can be written as
bst
D
=
I∑
j=1
(1{L2j−1 = s, L2j = t}+ 1{L2j−1 = t, L2j = s}) .
Moreover, ηs =
∑I
j=1 1{L2j−1 = s} +
∑I
j=1 1{L2j = s}. Therefore, conditional on ZN the(
K
2
)
+K vector VN := (BN , η1, . . . , ηK)
′ can be written as the sum of I i.i.d. random vectors.
This implies, under H0, as N →∞, by the multivariate CLT,
VN − EH0(VN )√
I
∣∣∣ZN D→ N(K2 )+K(0,Γ0), (A.7)
where
Γ0 := Cov(B, η¯1, η¯2, . . . , η¯K),
where
– B = ((1{L¯1 = s, L¯2 = t}))1≤s,t≤K , and
– η¯s = 1{L¯1 = s}+ 1{L¯2 = s}, and
– L¯1, L¯2 are i.i.d. random variables taking value s with probability ps, for 1 ≤ s ≤ K.
(This is the limit of the random variable L1 defined in (A.6).)
As the RHS in (A.7) does not depend on the conditioning event, the unconditional limit is
also the same:
VN − EH0(VN )√
I
D→ N(K2 )+K(0,Γ0).
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Then by [22, Theorem 2], there exists a
(
K
2
)× (K2 ) matrix Γ such that, under H0,
1√
N
(AN − EH0(AN )) D=
1√
N
(BN − EH0(BN )) |{(η1, . . . , ηK) = (N1, . . . , NK)}
D→ N(K2 )(0,Γ), (A.8)
which completes the proof of (1).
To see (2) note that the fourth moments of the elements of
AN−EH0 (AN )√
N
are bounded.
Therefore, by uniform integrability, 1N CovH0(AN ) → Γ. The invertibility of CovH0(AN )
(and hence Γ) follows from Lemma C.1 (in Appendix C). The result in (2.9) then follows
from (A.8) and an application of the Slutsky’s theorem.
A.3. Proof of Theorem 2.4. The entry-wise almost sure limit of 1NAN as in (2.13) is a
direct consequence of [3, Proposition 1] (by choosing φ =
∑K
s=1 psfs and φN =
1
N
∑K
s=1Nsfs
in [3, Proposition 1]).
Now, to prove consistency we need show that the test statistics have different limits under
the null and the alternative. To this end, we have the following lemma.
Lemma A.1. Let H(f1, f2, . . . , fK) be as defined in (2.14). Then
H(f1, f2, . . . , fK) ≤ H(f, f, . . . , f),
and equality holds if and only if f1 = f2 = · · · = fK outside a set of Lebesgue measure 0.
Proof. It follows from the Cauchy-Schwarz inequality, that for every s ∈ [K],
ˆ
Rd
p2s (fs(z))
2∑K
u=1 pufu(z)
dz ≥
(´
Rd psfs(z)dz
)2
´
Rd
∑K
u=1 pufu(z)dz
= p2s. (A.9)
This implies, H(f1, f2, . . . , fK) =
1
2 − tr(H) ≤ 12 − 12
∑K
s=1 p
2
s = H(f, f, . . . , f), as required.
Now, note that equality holds in (A.9) if and only if psfs = cs
∑K
u=1 pufu, for some constant
cs, almost everywhere. Integrating both sides of the last relation, gives cs = ps, that is, fs =∑K
u=1 pufu, almost everywhere. Therefore, equality holds if and only if f1 = f2 = · · · = fK ,
outside a set of Lebesgue measure 0. 
Now, suppose there exists 1 ≤ s 6= t ≤ K such that fs 6= ft on a set of positive Lebesgue
measure. By (2.13) and Lemma A.1, it follows that
RK,N − EH0(RK,N )
N
a.s.−−→ H(f1, f2, . . . , fk)−H(f, f, . . . , f) < 0,
and hence, 1√
N
(RK,N −EH0(RK,N )) a.s.−−→ −∞. Now, since the matrix CovH0(AN ) scales with
N (by Proposition 2.2), limN→∞ 1NVarH0(RK,N ) <∞. Hence,
lim
N→∞
QK,N = lim
N→∞
RK,N − EH0(RK,N )√
VarH0(RK,N )
a.s.−−→ −∞, (A.10)
which implies the limiting power of the MCM test limN→∞ PH1(QK,N < zα) = 1, proving
universal consistency.
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For the MMCM test note that under the alternative, 1N (AN − EH0AN )
a.s.−−→ ∆0 ∈ R(
K
2 ),
where sum of the entries of γ0 is H(f1, f2, . . . , fK) −H(f, f, . . . , f), that is, ∆0 is non-zero.
Now, since 1NCovH0(AN )→ Γ, where Γ is positive definite (by Proposition 2.2 and Lemma
C.1),
1
N
SK,N
a.s.−−→ ∆>0 Γ−1∆0 > 0,
that is, SK,N
a.s.−−→∞ under the alternative, proving universal consistency of the MMCM test.
Appendix B. Proof of Theorem 4.1
Recall the alternative way to describe the joint distribution of the data described in Section
4: Choose ZN := (Z1, Z2, . . . , ZN ) i.i.d. from the density φN =
∑K
s=1
Ns
N fs in R
d. Then given
ZN = (Z1, Z2, . . . , ZN ), assign a random label Lj ∈ [K] := {1, 2, . . . ,K} to Zj , independently
for each 1 ≤ j ≤ N , as in (4.1). Then it is easy to verify that the following fact, which is
proved in Appendix C.2.
Lemma B.1. The joint distribution of ({Zj : Lj = 1}, {Zj : Lj = 2}, . . . , {Zj : Lj = K}) con-
ditional on (η1, · · · , ηK) = (N1, N2, . . . , NK) is same as the joint distribution of the data(
X(1),X(2), . . . ,X(K)
)
, where ηs :=
∑N
i=1 1{Li = s}, the number of elements labelled s, for
1 ≤ s ≤ K.
The proof of Theorem 4.1 has two steps: (1) Computing the conditional covariance matrix
R(ZN ) := CovH1((B>N , η1, . . . , ηK−1)|ZN ) (as usual, BN denotes the vectorized upper trian-
gular part of the matrix BN defined in (4.2)), under the bootstrap alternative distribution
(which is the unconditional distribution of ({Zj : Lj = 1}, {Zj : Lj = 2}, . . . , {Zj : Lj = K})),
and show that scales with N (Section B.1), and (2) deriving the asymptotic normality of AN
from the joint distribution of the vector (B>N , η1, . . . , ηK−1)> under the bootstrap alternative
distribution (Section B.2).
B.1. Computing the Joint Conditional Covariance Matrix. Given the K densities
f1, f2, . . . , fK , we will begin by defining the matrix Γf1,f2,...,fK in Theorem 4.1. To this end,
let φ =
∑K
s=1 psfs and for each s, t ∈ [K], define the function hst : Rd × Rd 7→ [0, 1] as:
hst(x, y) :=
psptfs(x)ft(y)
φ(x)φ(y)
,
and set h¯st(x, y) := hst(x, y) + hst(y, x).
Definition B.1. (Defining the matrix Γf1,f2,...,fK ) Throughout, let Z ∼ φ =
∑K
s=1 psfs. To
begin with, let Q be a square matrix of dimension
(
K
2
)
+K − 1, partitioned as:
Q =
[
Q11 Q12
Q>12 Q22
]
, (B.1)
where Q11, Q12, and Q22 have dimensions
(
K
2
)× (K2 ), (K2 )× (K − 1) and (K − 1)× (K − 1),
respectively, and their elements are defined as follows:
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• The elements of the matrixQ11 will be denoted by q11((s, t), (u, v)), for 1 ≤ s < t ≤ K
and 1 ≤ u < v ≤ K, which is defined as:
q11((s, t), (u, v)) :=

1
2E
[
h¯st(Z,Z)(1− h¯st(Z,Z))
]
if (s, t) = (u, v),
−12E
[
h¯st(Z,Z)h¯uv(Z,Z)
]
otherwise.
(B.2)
• The elements of the matrix Q12 will be denoted by q12((s, t), u), for 1 ≤ s < t ≤ K
and 1 ≤ u ≤ K − 1, which is defined as:
q12((s, t), u) =

1
2E
[
h¯st(Z,Z)
(
1− 2pufu(Z)φ(Z)
)]
if u ∈ {s, t},
−E
[
h¯st(Z,Z)
(
pufu(Z)
φ(Z)
)]
otherwise.
(B.3)
• The elements of the matrix Q22 will be denoted by q22(s, t), for 1 ≤ s, t ≤ K − 1,
which is defined as:
q22(s, t) :=
{
ps(1− ps) if s = t,
−pspt otherwise. (B.4)
Finally, define
Γf1,f2,...,fK := Q11 −Q12Q−122 Q>12. (B.5)
To compute the limit of the covariance matrix R(ZN ) := CovH1((B>N , η1, . . . , ηK−1)|ZN ),
we need the following lemma from [3]. Recall φ :=
∑s
i=1 psfs.
Lemma B.2. [3, Proposition 1] Let Z1, Z2, . . . , ZN be i.i.d. from the density φN =
∑K
s=1
Ns
N fs,
and g : Rd × Rd 7→ [0, 1] be a symmetric, measurable function, such that almost any z ∈ Rd
is a Lebesgue continuity point of φ(·)g(z, ·). Then, as N →∞,
1
N
∑
1≤i<j≤N
e(Zi, Zj)g(Zi, Zj)
P−→ 12 Eg(Z,Z),
where e(x, y) := 1{(x, y) ∈ E(G (ZN ∪ {x, y})} and Z ∼ φ.
The following lemma uses the above result to show that the conditional covariance matrix
of (B>N , η1, . . . , ηK−1) divided by N , converges to a deterministic limit in probability.
Lemma B.3. Let R(ZN ) := CovH1((B>N , η1, . . . , ηK−1)|ZN ) be the conditional covariance
matrix under the bootstrap alternative distribution. Then
1
N
R(ZN ) P→ R :=
[
Q11 Q12
Q>12 R22
]
, (B.6)
where the matrices Q11 and Q12 are as defined in (B.2) and (B.3), respectively, and R22 =
((r22(s, t)))1≤s,t≤K−1, where
r22(s, t) :=

E
[
psfs(Z)
φ(Z)
(
1− psfs(Z)φ(Z)
)]
if s = t,
−E
[
psptfs(Z)ft(Z)
φ(Z)2
]
if s 6= t,
(B.7)
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with Z ∼ φ := ∑Ks=1 psfs, as before.
Proof. Let φN =
∑K
s=1
Ns
N fs, and recall that ηs =
∑N
j=1 1{Lj = s}, for s ∈ [K]. This implies,
for 1 ≤ s, 6= t ∈ [K − 1],
VarH1(ηs|ZN ) =
N∑
j=1
Ns
N fs(Zj)
φN (Zj)
(
1−
Ns
N fs(Zj)
φN (Zj)
)
,
and CovH1(ηs, ηt|ZN ) = −
∑N
j=1
Ns
N
Nt
N
fs(Zj)ft(Zj)
φN (Zj)2
. Hence, by the law of large numbers and
the dominated convergence theorem, as N →∞,
1
N
CovH1((η1, η2, . . . , ηK)
>|ZN ) P−→ R22, (B.8)
where R22 is as defined in (B.7).
Next, define h
(N)
st (x, y) :=
Ns
N
Nt
N
fs(x)fy(t)
φN (x)φN (y)
, and let h¯
(N)
st (x, y) := h
(N)
st (x, y)+h
(N)
st (x, y). Now,
for each 1 ≤ s < t ≤ K, the conditional variance of bst (recall (4.2)) is,
1
N
VarH1(bst
∣∣ZN ) = 1
N
∑
1≤i<j≤N
e(Zs, Zt)h¯
(N)
st (Zs, Zt)(1− h¯(N)st (Zs, Zt))
P−→ 1
2
E
[
h¯st(Z,Z)(1− h¯st(Z,Z))
]
, (B.9)
by Proposition B.2, as h¯
(N)
st → h¯st uniformly. Similarly, for any two distinct pairs (s, t) and
(u, v) with 1 ≤ s < t ≤ K and 1 ≤ u < v ≤ K,
1
N
CovH1(bst, buv
∣∣ZN ) P−→ −1
2
E
[
h¯st(Z,Z)h¯uv(Z,Z)
]
. (B.10)
Combining (B.9) and (B.10) gives
1
N
CovH1(B
>
N |ZN ) P−→ Q11, (B.11)
where Q11 is as defined in (B.2).
Finally, for each 1 ≤ s, t ≤ K and 1 ≤ u ∈ K − 1,
CovH1(bst, ηu
∣∣ZN ) = ∑
1≤s<t≤N
e(Zi, Zj)ψ
(N)
{(s,t),u}(Zi, Zj),
where
ψ
(N)
{(s,t),u}(Zi, Zj) =

h¯
(N)
st (Zi, Zj)
[
1−
Nu
N
fu(Zi)
φN (Zi)
−
Nu
N
fu(Zj)
φN (Zj)
]
if u ∈ {s, t}),
−h¯(N)st (Zi, Zj)
[
Nu
N
fu(Zi)
φN (Zi)
+
Nu
N
fu(Zj)
φN (Zj)
]
if u /∈ {s, t}.
Then by Lemma B.2, as N →∞,
1
N
CovH1(bst, ηu
∣∣ZN ) P−→ q12((s, t), u), (B.12)
where q12((s, t), u) is as in (B.3).
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The result in (B.6) now follows by combining (B.8), (B.11), and (B.12), completing the
proof of the lemma. 
B.2. The Joint Central Limit Theorem of the Cross-Counts. We now have all the
tools necessary for proving Theorem 4.1. Towards this, define
VN :=
1√
N
(
B>N − EH1(B>N
∣∣ZN ), η1 − EH1(η1∣∣ZN ), · · · , ηK−1 − EH1(ηK−1∣∣ZN ))> ,
a vector of length
(
K
2
)
+ K − 1. Define UN := R(ZN )− 12VN , where R(ZN ) = 1NR(ZN ), so
that EH1(UN |ZN ) = 0 and CovH1(UN
∣∣ZN ) = I, under the bootstrap alternative distribution.
For each (a, b) ∈ [N ]2, define the K ×K matrix Cab = ((Cab(s, t)))1≤s 6=t≤K , where,
Cab(s, t) := 1 {{La, Lb} = {s, t}} ,
for s 6= t and zero otherwise. Let Cab be the vector of length
(
K
2
)
obtained by concatenating
the rows of Cab in the upper triangular part. Now, for each (a, b) ∈ [N ]2, define:
Yab :=
(
C>ab, 1{La = 1}+ 1{Lb = 1}, · · · , 1{La = K − 1}+ 1{Lb = K − 1}
)>
,
and let Y ab :=
1√
N
R(ZN )− 12 (Yab − EH1(Yab|ZN )). Further, define S(ZN ) := {{a, b} ⊂ [N ] :
e(Za, Zb) = 1}. Then, it is easy to see that:
UN =
∑
{a,b}∈S(ZN )
Y ab.
Note that, under the bootstrap alternative distribution, given ZN , the collection {Y ab}{a,b}∈S(ZN )
is independent, so by an application of the multivariate Berry-Essen theorem [37, Theorem
1.1], we get:
sup
A∈C
∣∣∣P(UN ∈ A∣∣ZN )− Φ(K2 )+K−1(A)∣∣∣ ≤ L(K) ∑{a,b}∈S(ZN )E
(||Y ab||3∣∣ZN) , (B.13)
where C denotes the class of all measurable convex subsets of R(K2 )+K−1, Φ(K2 )+K−1(·) the
standard normal distribution function in dimension
(
K
2
)
+ K − 1, and L(K) is a constant
depending only on K.
Lemma B.4. Let Y ab be as defined above. Then
∑
{a,b}∈S(ZN ) E
(||Y ab||3∣∣ZN) P−→ 0, as
N →∞.
Proof. Note that every entry of the vector Yab − EH1(Yab|ZN ) is bounded in absolute value
by 2. Hence, ‖Yab−EH1(Yab|ZN )‖ ≤
√
2(K − 1)(K + 2). Consequently, denote the operator
norm of matrix by || · ||op
‖Y ab‖ ≤ 1√
N
∥∥∥R(ZN )− 12∥∥∥
op
∥∥Yab − E (Yab∣∣ZN)∥∥ ≤ (2(K − 1)(K + 2)
N
) 1
2
∥∥∥R(ZN )− 12∥∥∥
op
.
Then by the Cauchy-Schwarz inequality,∑
{a,b}∈S(Z)
E
(||Y ab||3∣∣ZN) ≤ √2(K − 1)3(K + 2)3
N
∥∥∥R(ZN )− 12∥∥∥3
op
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≤
√
2(K − 1)3(K + 2)3
N
[
tr
(
R(ZN )− 12
)]3
.
The RHS above converges to zero in probability, because by Lemma B.3 R(ZN ) converges
in probability. 
The lemma combined with (B.13) shows that, under the bootstrap alternative distribution,
the vector UN |ZN converges in distribution to N(K2 )+K−1(0, I), and by Lemma B.3 VN |ZN
converges in distribution to N(K2 )+K−1
(0,R), where R is as defined in (B.6). Hence, for every
vector t ∈ R(K2 )+K−1,
E
(
eit
>VN
∣∣∣ZN) P−→ E(eit>W) , (B.14)
where W ∼ N(K2 )+K−1(0,R). Next, define
BN :=
1√
N
(
0>, EH1(η1
∣∣ZN )−N1, · · · , EH1(ηK−1∣∣ZN )−NK−1)> ,
where the 0 here denotes a vector of all zeros of length
(
K
2
)
. Now, by the usual central limit
theorem, under the bootstrap alternative distribution, as N →∞ , BN D−→ N(K2 )(0,Ψ), where
Ψ :=
[
0 0
0 M
]
,
with the elements of M will be denoted by m(s, t), for 1 ≤ s, t ≤ K − 1, and
m(s, t) :=

VarZ∼φ
[
psfs(Z)
φ(Z)
]
if s = t,
CovZ∼φ
[
psfs(Z)
φ(Z) ,
ptft(Z)
φ(Z)
]
if s 6= t.
(B.15)
Now, recalling the definitions of the matrix Q (from (B.1)) and the matrix R (from (B.6)),
it is easy to see that Q = R + Ψ. Hence, by (B.14) and Lemma C.2 (putting AN = VN ,
CN = ZN and fN (CN ) = BN ), gives
1√
N
(
B>N − EH1(B>N |ZN ), ∆>N
)>
= VN +BN
D−→ N(K2 )(0,R+ Ψ)
D
= N(0,Q).
where ∆N := (η1 − N1, · · · , ηK−1 − NK−1)>. Therefore, by Lemma B.1 and (B.5), the
distribution of 1√
N
(B>N −EH1(B>N |ZN )) conditional on ∆N = 0, converges to N(K2 )(0,Q11−
Q12Q
−1
22 Q
>
12), as required.
Appendix C. Proofs of Technical Lemmas
Here, we collect the proofs of the different technical lemmas, required in the proofs above.
In Section C.1, we show the invertibility of the matrix CovH0(AN ). The proof of Lemma B.1
is given in Section C.2. Other technical lemma used in the proof of Theorem B are proved
in Section C.3.
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C.1. Invertibility of the Count Matrix Under the Null. In order for the MCMM
statistic to be well-defined, we need to make sure the matrix CovH0(AN ) (recall Proposition
2.2) is invertible. This is proved in the following lemma:
Lemma C.1. The matrix CovH0(AN ) is invertible.
Proof. For simplicity, we assume that the sample sizes Ns are even, for all 1 ≤ s ≤ K. For
1 ≤ r < s ≤ K, define a K ×K matrices ars = ((ars(u, v)))1≤u,v≤K as follows:
ars(r, s) = ars(s, r) = min{Nr, Ns},
ars(u, v) = 0, for all {u, v} 6= {r, s} and u 6= v,
ars(r, r) =
1
2(Nr −min{Nr, Ns}),
ars(s, s) =
1
2(Ns −min{Nr, Ns}),
ars(u, u) =
1
2Nu, for all u 6= {r, s}.
Clearly, ars ∈ B (recall Proposition 2.1), which implies, by (2.6), PH0(AN = ars) > 0, for
all 1 ≤ r < s ≤ K. Now, as in (2.5), denote by ars the vector of length
(
K
2
)
obtained by
concatenating the rows of ars in the upper triangular part. The argument above shows that
PH0(AN = ars) > 0, for all 1 ≤ r < s ≤ K. Moreover, also note that PH0(AN = 0) > 0,
where 0 denotes the vector of length
(
K
2
)
with all entries 0. Also, note that the vectors
{ars}1≤r<s≤K , each of which has only have one non-zero element corresponding to the element
ars(r, s), form a basis of R(
K
2 ).
Now, suppose that CovH0(AN ) is singular, whence there exists a non-zero vector η ∈ R(
K
2 )
such that CovH0(AN )η = 0. This implies that VarH0(η
>AN ) = 0, and hence,
PH0
(
η>AN = EH0(η>AN )
)
= 1. (C.1)
The fact PH0(AN = 0) > 0, now implies that EH0(η>AN ) = 0 (otherwise, assuming
EH0(η>AN ) 6= 0, leads to, by (C.1), PH0(AN = 0) ≤ PH0(η>AN = 0) = 0, which is
a contradiction). Again, since PH0(AN = ars) > 0, it follows that η>ars = 0, for all
1 ≤ r < s ≤ K. This implies, since the vectors {ars}1≤r<s≤K form a basis of R(
K
2 ), η = 0,
which is a contradiction. 
C.2. Proof of Lemma B.1. For notational convenience, we will prove the result only for the
case K = 2. The proof for general K follows similarly. We begin with a few notations: Let
Π denote the set of all permutations σ of [N ], such that σ(a) < σ(b), for all 1 ≤ a < b ≤ N1,
and σ(a) < σ(b), for all N1 + 1 ≤ a < b ≤ N1 +N2 = N . Moreover, for a vector x ∈ Rd and
a Rd-valued random variable X, we denote by {X ≤ x} the event {X ∈ {y ∈ Rd : y ≤ x}}.9
Now, considering the sets {Zi : Li = 1} and {Zi : Li = 2} as vectors with the indices
arranged in increasing order, it follows that
({Zi : Li = 1}, {Zi : Li = 2}) = (Zpi(1), · · · , Zpi(N)),
where pi is a random permutation of [N ], such that pi(1) < pi(2) · · · < pi(η1) and pi(η1 + 1) <
pi(η1 + 2) · · · < pi(η1 + η2), where Lpi(a) = 1, for all 1 ≤ a ≤ η1, and Lpi(a) = 2, for all
9For any two vectors u = (u1, u2, . . . , ud) ∈ Rd and v = (v1, v2, . . . , vd) ∈ Rd, we write u ≤ v, if ua ≤ va, for
all 1 ≤ a ≤ d.
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η1 + 1 ≤ a ≤ η1 + η2. Then, for every z1, · · · , zN ∈ Rd,
P
(
Zpi(1) ≤ z1, · · · , Zpi(N) ≤ zN
∣∣∣∣∣η1 = N1
)
=
1
P(η1 = N1)
∑
σ∈Π
P
(
Zσ(1) ≤ z1, · · · , Zσ(N) ≤ zN , pi = σ, η1 = N1
)
=
1
P(η1 = N1)
∑
σ∈Π
P
 N1⋂
a=1
{
Zσ(a) ≤ za, Lσ(a) = 1
}⋂ N1+N2⋂
a=N1+1
{
Zσ(a) ≤ za, Lσ(a) = 2
}
=
|Π|
P(η1 = N1)
N1∏
a=1
P (Za ≤ za, La = 1)
N1+N2∏
a=N1+1
P (Za ≤ za, La = 2)
=
(
N
N1
)
P(η1 = N1)
N1∏
a=1
N1
N
F1(za)
N1+N2∏
a=N1+1
N2
N
F2(za)
=
N1∏
a=1
F1(za)
N1+N2∏
a=N1+1
F2(za) (using P(η1 = N1) =
(
N
N1
) (
N1
N
)N1 (N2
N
)N2
)
= P(X(1)1 ≤ z1, · · · , X(1)N1 ≤ zN1 , X
(2)
1 ≤ zN1+1, · · · , X(2)N2 ≤ zN1+N2),
which completes the proof of the lemma. 
C.3. Missing Details in the Proof of Theorem 4.1. Here, we provide the proof of a
lemma used in the proof of Theorem 4.1.
Lemma C.2. Let {XN}N≥1 be a sequence of Rp-valued random vectors, for some p ≥ 1, and
CN be a sequence random variable, such that E(eit
>XN |CN ) P→ a, for some real number a
and some vector t ∈ Rp. Moreover, suppose that fN is a sequence of deterministic functions
with codomain Rp, such that E(eit>fN (CN ))→ b, for some real number b. Then,
lim
N→∞
E
(
eit
>(AN+fN (CN ))
)
= ab.
Proof. Note that,∣∣∣E(eit>(AN+fN (CN )))− ab∣∣∣ = ∣∣∣E [eit>fN (CN )E(eit>AN ∣∣CN)]− ab∣∣∣
≤
∣∣∣E [eit>fN (CN ) (E(eit>AN ∣∣CN)− a)] ∣∣∣+ |a|∣∣∣E [eit>fN (CN ) − b] ∣∣∣
≤ E
∣∣∣E(eit>AN ∣∣CN)− a∣∣∣+ |a|∣∣∣E(eit>fN (CN ) − b) ∣∣∣.
The first term in the last expression goes to 0 by hypothesis and the dominated convergence
theorem, while the last term goes to 0 by hypothesis, completing the proof. 
Appendix D. Additional Simulations
In this section, we present simulations comparing the empirical powers of the MCM and
the MMCM tests for location, spherical scale, and equi-correlation scale changes in the log
normal family. As before, in all the simulations, the power is calculated over 100 iterations,
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the tests are implemented using the permutation distribution, and the nominal level is chosen
to be 0.05.
∆ ↓ Dimension 5 10 50 100 200 300 500
.06
MCM .13 .17 .49 .65 .81 .88 .90
MMCM .10 .18 .42 .68 .93 .98 .99
.08
MCM .15 .19 .52 .68 .87 .95 1.0
MMCM .12 .20 .70 .92 .98 1.0 1.0
.10
MCM .19 .26 .79 .85 .96 1.0 1.0
MMCM .18 .31 .94 1.0 1.0 1.0 1.0
.12
MCM .50 .69 1.0 1.0 1.0 1.0 1.0
MMCM .49 .84 1.0 1.0 1.0 1.0 1.0
(a)
∆ ↓ Groups 4 6 8 10
.04
MCM .13 .22 .49 .71
MMCM .10 .16 .63 .99
.06
MCM .21 .35 .85 1.0
MMCM .14 .41 .98 1.0
.08
MCM .37 .92 1.0 1.0
MMCM .31 1.0 1.0 1.0
.10
MCM .52 1.0 1.0 1.0
MMCM .56 1.0 1.0 1.0
(b)
Table 6. Power of the MCM and the MMCM tests in the lognormal location family
with (a) the number of classes K = 6 fixed, and (b) the dimension d = 150 fixed.
• Lognormal Location: Here, we consider samples from the following K log-normal
distributions: exp(Nd((s−1)∆ ·1, I)), for 1 ≤ s ≤ K. Table 6(a) shows the fixed class
scenario, where we take K = 6 groups and vary the dimension d from 5 to 500, and ∆
from 0.06 to 0.12. Table 6(b) shows the fixed dimension scenario, where the dimension
d = 150 is fixed, the number of groups K varies along 4, 6, 8, 10, and ∆ varies from
0.04 to 0.10. In both cases, the sample sizes were taken in equal increments of 50,
starting from 50.
∆ ↓ Dimension 5 10 50 100 200 300 500
.15
MCM .15 .21 .44 .70 .94 .99 1.0
MMCM .13 .17 .66 .99 1.0 1.0 1.0
.20
MCM .16 .22 .70 .96 1.0 1.0 1.0
MMCM .18 .35 .96 1.0 1.0 1.0 1.0
.25
MCM .17 .23 .87 .97 1.0 1.0 1.0
MMCM .10 .37 .98 1.0 1.0 1.0 1.0
.30
MCM .18 .27 .91 1.0 1.0 1.0 1.0
MMCM .21 .46 1.0 1.0 1.0 1.0 1.0
.35
MCM .13 .42 1.0 1.0 1.0 1.0 1.0
MMCM .20 .51 1.0 1.0 1.0 1.0 1.0
.40
MCM .34 .73 1.0 1.0 1.0 1.0 1.0
MMCM .25 .96 1.0 1.0 1.0 1.0 1.0
(a)
∆ ↓ Groups 4 6 8 10
.15
MCM .39 .91 .99 1.0
MMCM .48 1.0 1.0 1.0
.20
MCM .75 .99 1.0 1.0
MMCM .86 1.0 1.0 1.0
.25
MCM .93 1.0 1.0 1.0
MMCM .99 1.0 1.0 1.0
.30
MCM .98 1.0 1.0 1.0
MMCM 1.0 1.0 1.0 1.0
.35
MCM .99 1.0 1.0 1.0
MMCM 1.0 1.0 1.0 1.0
.40
MCM 1.0 1.0 1.0 1.0
MMCM 1.0 1.0 1.0 1.0
(b)
Table 7. Power of the MCM and the MMCM tests in the lognormal spherical scale
family with (a) the number of classes K = 6 fixed, and (b) the dimension d = 150
fixed.
• Spherical Lognormal Scale: Here, we consider samples from the following K log-
normal distributions: exp(Nd(0, (1 + (s − 1)∆)I)), for 1 ≤ s ≤ K. Table 7(a) shows
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∆ ↓ Dimension 5 10 50 100 200 300 500
.15
MCM .08 .09 .14 .16 .23 .31 .32
MMCM .05 .10 .11 .14 .18 .23 .27
.20
MCM .09 .11 .16 .13 .24 .25 .34
MMCM .08 .11 .13 .22 .25 .27 .39
.25
MCM .07 .11 .17 .26 .30 .36 .43
MMCM .02 .08 .12 .25 .33 .45 .53
.30
MCM .06 .14 .15 .26 .38 .45 .52
MMCM .10 .15 .23 .36 .54 .68 .71
.35
MCM .07 .15 .28 .32 .45 .57 .72
MMCM .08 .16 .28 .43 .69 .77 .89
.40
MCM .20 .22 .37 .45 .72 .75 .84
MMCM .16 .24 .48 .63 .95 .99 1.0
(a)
∆ ↓ Groups 4 6 8 10
.15
MCM .20 .14 .12 .11
MMCM .14 .15 .12 .11
.20
MCM .28 .18 .13 .14
MMCM .22 .19 .18 .16
.25
MCM .31 .31 .27 .21
MMCM .37 .32 .19 .16
.30
MCM .41 .35 .29 .23
MMCM .42 .40 .31 .30
.35
MCM .47 .39 .38 .33
MMCM .55 .51 .48 .45
.40
MCM .63 .52 .49 .47
MMCM .79 .77 .68 .63
(b)
Table 8. Power of the MCM and the MMCM tests in the lognormal equi-correlated
scale family with (a) the number of classes K = 6 fixed, and (b) the dimension d = 150
fixed.
the fixed class scenario, with K = 6 and dimension d varying from 5 to 500, and ∆
varying from 0.15 to 0.4. As before, in this case, the sample sizes were taken in equal
increments of 50, starting from 50. Table 7(b) shows the fixed dimension scenario,
where the d = 150 is fixed, and K varies along 4, 6, 8, 10, and ∆ varies from 0.15 to
0.4, as well. Here, the sample sizes are taken in equal increments from 50 to 200 when
K = 4, from 50 to 300 when K = 6, from 50 to 260 when K = 8, and from 50 to 230
when K = 10.
• Equi-correlated Lognormal Scale: Here, we consider samples from the following K
log-normal distributions: exp(Nd(0, (1− ρs)I + ρs11>)), where ρs := (s− 1) ∆K−1 , for
1 ≤ s ≤ K. Table 8(a) shows the fixed class scenario, with K = 6 and dimension d
varying from 5 to 500, and ∆ varying from 0.15 to 0.4. The sample sizes are taken
to be 50, 100, 150, 200, 250 and 300. Table 8(b) shows the fixed dimension scenario,
where the d = 150 is fixed, and K varies along 4, 6, 8, 10, and ∆ varies from 0.15 to
0.4, as before. The sample sizes are taken in equal increments from 50 to 200 when
K = 4, from 50 to 300 when K = 6, from 50 to 260 when K = 8, and from 50 to 230
when K = 10.
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